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Introduction {#sec006}
============

Breast cancer (BC) is one of the most common diseases and an important public health challenge among women worldwide, although the incidences of BC are not the same in different countries and ethnic groups \[[@pone.0216147.ref001], [@pone.0216147.ref002]\]. Risk factors that have been confirmed including age, family history and several reproductive factors only explain one-third of BC cases \[[@pone.0216147.ref003]\]. Studies on the pathologic mechanism of BC remain enigmatic, and it is a multifactorial and polygenic disease which may be influenced by both environmental and genetic factors \[[@pone.0216147.ref004], [@pone.0216147.ref005]\]. Therefore, studies on gene polymorphisms have become much more important in the progression of BC worldwide \[[@pone.0216147.ref006], [@pone.0216147.ref007]\].

In recent years, some genes have been confirmed as potential cancer susceptible genes. Glutathione S-transferases (*GSTs*) are overwhelmingly important genes, which play key role in the detoxification of toxic, potentially carcinogenic compounds, and a host of basic physiological processes of the human body \[[@pone.0216147.ref008]--[@pone.0216147.ref011]\]. In human, five classes of *GST* enzymes have been found (α,μ,π,σ, andθ) \[[@pone.0216147.ref012]\] and each class is encoded by an independent gene or family genes (such as *GSTA*, *GSTM*, *GSTP*, *GSTO*, and *GSTT* genes). Among these genes, both *GSTM1* and *GSTT1* genes show deletion polymorphisms (null genotype) \[[@pone.0216147.ref013], [@pone.0216147.ref014]\], which cause the absence of expression and enzyme activity loss \[[@pone.0216147.ref015]\]. They are located on chromosome 1 (1p13.3) and chromosome 22 (22q11.2), respectively \[[@pone.0216147.ref016]\]. An codon 105 A to G mutation at exon 5 in *GSTP1* polymorphism results in a change isoleucine (IIe) to valine (Val), which also decreases enzymatic activity \[[@pone.0216147.ref017], [@pone.0216147.ref018]\]. Therefore, the three gene mutations may increase BC risk on the basis of their biological effects.

In 1993, the first publication was reported on the association between *GSTM1* null genotype and BC cancer susceptibility \[Reference 1 in [S1 Appendix](#pone.0216147.s032){ref-type="supplementary-material"}\]. The first study investigated the association between individual *GSTT1* null genotype and the combined effects of *GSTM1* present/null, *GSTT1* present/null, and *GSTP1* IIe105Val polymorphisms on BC cancer risk was published in 1998 \[Reference 5 in [S1 Appendix](#pone.0216147.s032){ref-type="supplementary-material"}\], and it is the first article that was published to explore the association between *GSTP1* IIe105Val polymorphism and BC cancer risk \[Reference 110 in [S1 Appendix](#pone.0216147.s032){ref-type="supplementary-material"}\]. So far, 116 publications \[References 1--116 in [S1 Appendix](#pone.0216147.s032){ref-type="supplementary-material"}\] have been reported on these themes. Nevertheless, the results of these studies were contradictory. Fourteen previous meta-analyses \[[@pone.0216147.ref019]--[@pone.0216147.ref032]\] have been published to analyze the individual *GSTM1* present/null, *GSTT1* present/null, and *GSTP1* IIe105Val polymorphisms on BC risk. However, their meta-analyses did not conduct the combined effects of the three genes on BC risk, in addition, they did not evaluate the credibility of statistically significant associations, furthermore, a lot of new studies have been published, and therefore a meta-analysis and re-analysis of previous meta-analyses were carried out to further explore the individual and combined effects of these genes on BC risk.

Materials and methods {#sec007}
=====================

Search strategy {#sec008}
---------------

Literature search was performed using PubMed and CNKI databases in this meta-analysis (update to 18 May, 2018). The following search strategy was applied: (glutathione S-transferase T1 OR *GSTT1* OR glutathione S-transferase P1 OR *GSTP1* OR glutathione S-transferase M1 OR *GSTM1*) AND breast AND (polymorphism OR genotype OR allele OR variant OR mutation). Language was not restricted in the present meta-analysis. It was implemented to identify additional studies manually (references of the original and review studies). Finally, the corresponding authors were contacted via e-mail if necessary.

Inclusion and exclusion criteria {#sec009}
--------------------------------

The eligible publications were selected applying the following criteria: (1) case--control study; (2) detailed genotype frequencies were afforded between case and control groups; (3) studies must assess the association between the individual and combined effects of *GSTM1* present/null, *GSTT1* present/null and *GSTP1* IIe105Val polymorphisms on BC risk. Studies were removed if they were case reports, duplicate data or incomplete data, meta-analysis, and so on.

Data extraction {#sec010}
---------------

Information was carefully collected independently by two investigators from all selected studies. Potential disagreements were judged through the corresponding authors if necessary. The following information was collected: first author's surname, year of publication, country, ethnicity, source of cases, source of controls, type of controls, matching, single nucleotide polymorphism (SNP), sample size, and genotype frequencies of the individual and combined effects of *GSTM1*, *GSTT1* and *GSTP1* polymorphisms on BC risk.

Quality score assessment {#sec011}
------------------------

The quality of the studies were appraised independently by two of all authors. We designed quality assessment criteria on the basis of two previous meta-analyses \[[@pone.0216147.ref033], [@pone.0216147.ref034]\]. [S1 Table](#pone.0216147.s001){ref-type="supplementary-material"} lists the scale for quality assessment of molecular association studies of BC. [S3](#pone.0216147.s003){ref-type="supplementary-material"} and [S4](#pone.0216147.s004){ref-type="supplementary-material"} Tables list the quality assessment by included studies of *GSTM1* present/null, *GSTT1* present/null, and *GSTP1* IIe105Val polymorphisms with BC risk. They were considered as low quality studies if quality scores were ≤10, while scores of \> 10 were regarded as high quality in this meta-analysis.

Statistical analysis {#sec012}
--------------------

We applied crude odds ratios (ORs) and their 95% confidence intervals (CIs) to estimate the association between individual and combined effects of *GSTM1* present/null, *GSTT1* present/null, and *GSTP1* IIe105Val polymorphisms on BC risk. We used null vs. present model to calculate the pooled ORs with their 95% CIs for the *GSTM1* present/null and *GSTT1* present/null polymorphisms. Analysis was conducted employing the following genetic models for *GSTP1* IIe105Val polymorphism: Val/Val vs. IIe/IIe, IIe/Val vs. IIe/IIe, Val/Val vs. IIe/IIe + IIe/Val, Val/Val + IIe/Val vs. IIe/IIe, and Val vs. IIe. For the combined effects of *GSTM1* present/null and *GSTT1* present/null polymorphisms, we applied the following genetic models: + *−* vs. + +, *−* + vs. + +, *− −* vs. + +, (+ *−*) + (*−* +) vs. + +, (− −) + (+ *−*) + (*−* +) vs. + +, and *− −* vs. (+ +) + (+ *−*) + (*−* +). *− −* was *GSTM1* null/*GSTT1* null, + + was *GSTM1* present/*GSTT1* present, + *−* was *GSTM1* present/*GSTT1* null, and *−* + was *GSTM1* null/*GSTT1* present. The following genetic models were used for the combined effects of *GSTM1* present/null and *GSTP1* IIe105Val polymorphisms: *GSTM1* null/*GSTP1* IIe/IIe vs. *GSTM1* present/*GSTP1* IIe/IIe, *GSTM1* present/*GSTP1* Val\* vs. *GSTM1* present/*GSTP1* IIe/IIe, all one high risk genotypes vs. *GSTM1* present/*GSTP1* IIe/IIe, *GSTM1* null/*GSTP1* Val\* vs. *GSTM1* present/*GSTP1* IIe/IIe, all high risk genotypes vs. *GSTM1* present/*GSTP1* IIe/IIe, and *GSTM1* null/*GSTP1* Val\* vs. (*GSTM1* null/*GSTP1* IIe/IIe + *GSTM1* present/*GSTP1* Val\* + *GSTM1* present/*GSTP1* IIe/IIe). For the combined effects of *GSTT1* present/null and *GSTP1* IIe105Val polymorphisms, the following genetic models were employed: *GSTT1* null/*GSTP1* IIe/IIe vs. *GSTT1* present/*GSTP1* IIe/IIe, *GSTT1* present/*GSTP1* Val\* vs. *GSTT1* present/*GSTP1* IIe/IIe, all one high risk genotypes vs. *GSTT1* present/*GSTP1* IIe/IIe, *GSTT1* null/*GSTP1* Val\* vs. *GSTT1* present/*GSTP1* IIe/IIe, all high risk genotypes vs. *GSTT1* present/*GSTP1* IIe/IIe, and *GSTT1* null/*GSTP1* Val\* vs. (*GSTT1* null/*GSTP1* IIe/IIe + *GSTT1* present/*GSTP1* Val\* + *GSTT1* present/*GSTP1* IIe/IIe). Finally, for the combined effects of *GSTM1* present/null, *GSTT1* present/null, and *GSTP1* IIe105Val polymorphisms, we applied the following ten genetic models: *GSTM1* null/*GSTT1* present/*GSTP1* IIe/IIe vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe, *GSTM1* present/*GSTT1* null/*GSTP1* IIe/IIe vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe, *GSTM1* present/*GSTT1* present/*GSTP1* Val\* vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe, all one high-risk genotypes vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe, *GSTM1* null/*GSTT1* null/*GSTP1* IIe/IIe vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe, *GSTM1* null/*GSTT1* present/*GSTP1* Val\* vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe, *GSTM1* present/*GSTT1* null/*GSTP1* Val\* vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe, all two high-risk genotypes vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe, *GSTM1* null/*GSTT1* null//*GSTP1* Val\* vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe, and *GSTM1* null/*GSTT1* null//*GSTP1* Val\* vs. (all one high-risk genotypes + all two high-risk genotypes + *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe). We employed *Q* test to evaluate heterogeneity among selected studies. A statistically significant heterogeneity was regarded if *P* \< 0.10 and *I*^*2*^ \> 50% \[[@pone.0216147.ref035]\]. A fixed-effects model \[[@pone.0216147.ref036]\] was considered if the heterogeneity was not notable, if not, a random-effects model was used \[[@pone.0216147.ref037]\]. Subgroup analyses were conducted on the basis of ethnicity, source of controls, type of controls, sample size, quality score, matching, menopausal status, smoking habits, and Hardy-Weinberg equilibrium (HWE). Chi-square goodness-of-fit test was applied to check HWE, and significant deviation was considered in control groups if *P* \< 0.05. Heterogeneity sources were estimated according to a meta-regression analysis method. A sensitivity analysis was performed by using two methods: first, a single study was removed each time, second, a dataset was used that the comprised only high-quality studies, matching studies, HWE, and genotyping performed blindly or with quality control \[[@pone.0216147.ref038]\]. Publication bias was confirmed on the basis of Begg's funnel plot \[[@pone.0216147.ref039]\] Egger's test (significant publication bias was considered if *P* \< 0.05) \[[@pone.0216147.ref040]\]. A nonparametric 'trim and fill' method was applied to accredit missing studies \[[@pone.0216147.ref041]\] if publication bias was observed. To evaluate the credibility of statistically significant associations in the current and previous meta-analyses, we applied the false-positive report probabilities (FPRP) test \[[@pone.0216147.ref042]\] and the Venice criteria \[[@pone.0216147.ref043]\]. The FPRP was estimated using an Excel spreadsheet [S2 Appendix](#pone.0216147.s033){ref-type="supplementary-material"}. All statistical analyses were calculated using STATA version 9.0 (STATA Corporation, College Station, TX).

Results {#sec013}
=======

Study characteristics {#sec014}
---------------------

[Fig 1](#pone.0216147.g001){ref-type="fig"} lists the flow diagram for identifying and including studies in the current meta-analysis. 354 titles met the search criteria. 238 articles were excluded because they were review articles, case reports, other genes, and meta-analyses. In addition, fifteen articles \[References 2, 4, 10, 21, 31, 32, 33, 35, 45, 54, 76, 82, 91, 107, 115 in [S1 Appendix](#pone.0216147.s032){ref-type="supplementary-material"}\] were removed because their sample had been overlapped with another eleven studies \[8, 9, 17, 23, 41, 47, 55, 64, 71, 88, 105 in [S1 Appendix](#pone.0216147.s032){ref-type="supplementary-material"}\]. In the end, 101 publications were selected to evaluate the individual and combined effects of *GSTM1* present/null, *GSTT1* present/null, and *GSTP1* IIe105Val polymorphisms on BC risk. [S2 Table](#pone.0216147.s002){ref-type="supplementary-material"} shows the general characteristics of studies included in this meta-analysis. There were 88 case--control studies from 82 publications on *GSTM1* present/null polymorphism (involving 28,676 BC cases and 32,539 controls, [S5 Table](#pone.0216147.s005){ref-type="supplementary-material"}), 67 case--control studies from 62 publications on *GSTT1* present/null polymorphism (involving 23,092 BC cases and 26,381 controls, [S5 Table](#pone.0216147.s005){ref-type="supplementary-material"}), 56 case--control studies from 53 articles on *GSTP1* IIe105Val polymorphism (involving 25,331 BC cases and 27,424 controls, [S5 Table](#pone.0216147.s005){ref-type="supplementary-material"}), 31 case--control studies from 30 articles on the combined effects of both *GSTM1* and *GSTT1* null genotypes (involving 10,497 BC cases and 10,242 controls, [S8 Table](#pone.0216147.s008){ref-type="supplementary-material"}), 15 case--control studies on the combined effects of *GSTM1* present/null and *GSTP1* IIe105Val polymorphisms (involving 6,272 BC cases and 6,739 controls, [S10 Table](#pone.0216147.s010){ref-type="supplementary-material"}), 13 case--control studies on the combined effects of *GSTT1* present/null and *GSTP1* IIe105Val polymorphisms (involving 5,413 BC cases and 5,567 controls, [S11 Table](#pone.0216147.s011){ref-type="supplementary-material"}), and 13 case--control studies on the combined effects of three *GSTM1* present/null, *GSTT1* present/null, and *GSTP1* IIe105Val polymorphisms (involving 5,395 BC cases and 5,544 controls, [S12 Table](#pone.0216147.s012){ref-type="supplementary-material"}). In addition, twenty, fifteen, ten, and seven case--control studies were conducted to analyze *GSTM1* null genotype (including 7,934 BC cases and 11,059 controls), *GSTT1* null genotype (including 6,786 BC cases and 9,477 controls), *GSTP1* IIe105Val (including 3,448 BC cases and 3,676 controls), and the combined effects of *GSTM1* and *GSTT1* polymorphisms (including 1,916 BC cases and 2,268 controls) among postmenopausal women, and seventeen, twelve, fifteen, and six case--control studies were conducted to analyze *GSTM1* null genotype (including 2,840 BC cases and 3,393 controls), *GSTT1* null genotype (including 1,605 BC cases and 1,830 controls), *GSTP1* IIe105Val (including 8,493 BC cases and 11,040 controls), and the combined effects of *GSTM1* and *GSTT1* polymorphisms (including 981 BC cases and 1,185 controls) among premenopausal women, respectively, as shown in [S6](#pone.0216147.s006){ref-type="supplementary-material"}--[S9](#pone.0216147.s009){ref-type="supplementary-material"} Tables. Furthermore, there were five, three, and zero current smoking studies, seven, six, and one past smoking studies, and eleven, nine, and three no-smoking studies on *GSTM1*, *GSTT1*, and *GSTP1* polymorphisms, respectively, as shown in [S7 Table](#pone.0216147.s007){ref-type="supplementary-material"}. Finally, there were 31 high-quality studies and 57 low-quality studies on *GSTM1* present/null, 23 high-quality studies and 44 low-quality studies on *GSTT1* present/null, 30 high-quality studies and 26 low-quality studies on *GSTP1* IIe105Val, 13 high-quality studies and 18 low-quality studies on the combined effects of *GSTM1* and *GSTT1*, nine high-quality studies and six low-quality studies on the combined effects of *GSTM1* and *GSTP1*, eight high-quality studies and five low-quality studies on the combined effects of *GSTT1* and *GSTP1*, and eight high-quality studies and five low-quality studies on the combined effects of *GSTM1*, *GSTT1*, and *GSTP1* polymorphisms as determined by quality assessment of molecular association studies ([S1 Table](#pone.0216147.s001){ref-type="supplementary-material"}).

![Flow diagram for identifying and including studies in the current meta-analysis.](pone.0216147.g001){#pone.0216147.g001}

Quantitative synthesis {#sec015}
----------------------

At the overall analysis, the *GSTM1* null genotype was associated with elevated BC risk (OR = 1.12, 95% CI = 1.06--1.09). In addition, significantly elevated BC risk was also observed in a slice of subgroups, such as Asians, population-based studies, healthy women, cancer-free women, cancer-free patients, matching studies, no matching studies, large-sized studies, small-sized studies, high-quality studies, low-quality studies, postmenopausal and premenopausal women, as shown in [Table 1](#pone.0216147.t001){ref-type="table"}.

10.1371/journal.pone.0216147.t001

###### Meta-analysis of the association of *GSTM1* polymorphism with risk of breast cancer.

![](pone.0216147.t001){#pone.0216147.t001g}

  Variable               n    Cases/Controls   Test of association       Test of heterogeneity   
  ---------------------- ---- ---------------- ------------------------- ----------------------- ------
  Overall                88   28,676/32,539    **1.12 (1.06--1.19)**\*   \<0.001                 59.9
  Ethnicity                                                                                      
  African                6    1,177/1,171      0.92 (0.77--1.10)         0.964                   0.0
  Indian                 7    1,597/1,702      1.36 (0.95--1.95)\*       \<0.001                 78.5
  Asian                  19   5,690/7,536      **1.20 (1.05--1.38)**\*   \<0.001                 66.5
  Caucasian              37   13,357/15,573    1.05 (0.97--1.13)\*       0.001                   48.3
  Source of controls                                                                             
  HB                     41   7,561/7,956      1.07 (0.96--1.19)\*       \<0.001                 55.1
  PB                     28   17,240/21,204    **1.15 (1.06--1.25)**\*   \<0.001                 69.1
  Type of controls                                                                               
  Healthy women          28   6,436/7,087      **1.21 (1.06--1.39)\***   \<0.001                 67.7
  Cancer-free women      47   20,264/23,502    **1.07 (1.00--1.13)\***   \<0.001                 46.6
  Cancer-free patients   8    893/863          **1.50 (1.05--2.14)**\*   0.007                   63.7
  Matching                                                                                       
  Yes                    46   19,528/23,342    **1.07 (1.02--1.13)\***   0.039                   28.7
  No                     42   9,148/9,197      **1.19 (1.05--1.34)\***   \<0.001                 72.0
  Sample size                                                                                    
  ≥ 200                  68   27,454/31,024    **1.09 (1.03--1.16)\***   \<0.001                 62.2
  \< 200                 20   1,222/1,515      **1.41 (1.14--1.74)\***   0.041                   38.6
  Quality score                                                                                  
  \>10                   31   19,002/23,225    **1.07 (1.03--1.11)**     0.555                   0.0
  ≤10                    57   9,674/9,314      **1.18 (1.05--1.32)\***   \<0.001                 69.4
  Menopausal status                                                                              
  Postmenopausal         20   7,934/11,059     **1.17 (1.05--1.30)\***   0.006                   50.1
  Premenopausal          17   2,840/3,393      **1.18 (1.01--1.38)\***   0.014                   48.3
  Smoking habits                                                                                 
  Current smoker         5    288/334          1.32 (0.96--1.82)         0.659                   0.0
  Past smoker            7    940/1,000        1.08 (0.91--1.30)         0.943                   0.0
  Never                  11   1,616/1,877      0.98 (0.86--1.13)         0.293                   15.8

HB: hospital-based studies; PB: population-based studies

The characters who carried *GSTT1* null genotype had a significantly elevated BC risk (OR = 1.15, 95% CI = 1.06--1.25) in overall analysis. Significant association was also shown in quite a few subgroups, for instance, Caucasians, hospital-based studies, healthy women, cancer-free patients, matching studies, no matching studies, large-sized studies, small-sized studies, low-quality studies, and premenopausal women, as shown in [Table 2](#pone.0216147.t002){ref-type="table"}.

10.1371/journal.pone.0216147.t002

###### Meta-analysis of the association of *GSTT1* polymorphism with risk of breast cancer.

![](pone.0216147.t002){#pone.0216147.t002g}

  Variable               n    Cases/Controls   Test of association           Test of heterogeneity   
  ---------------------- ---- ---------------- ----------------------------- ----------------------- ------
  Overall                67   23,092/26,381    **1.15 (1.06--1.25)**\*       \<0.001                 63.4
  Ethnicity                                                                                          
  African                5    1,166/1,095      1.11 (0.92--1.35)             0.202                   32.9
  Asian                  15   3,751/5,425      1.18 (0.95--1.47)\*           \<0.001                 80.2
  Caucasian              27   11,139/12,652    **1.20 (1.07--1.34)**\*       0.006                   45.7
  Indian                 7    1,596/1,702      1.34 (0.94--1.92)\*           0.002                   70.6
  Source of controls                                                                                 
  HB                     29   4,947/5,489      **1.19 (1.03--1.37)\***       0.001                   52.3
  PB                     23   15,291/18,337    1.07 (0.96--1.19)\*           \<0.001                 72.5
  Type of controls                                                                                   
  Healthy women          22   4,353/5,048      **1.32 (1.09--1.60)\***       \<0.001                 68.5
  Cancer-free women      36   17,277/19,860    1.04 (0.96--1.14)\*           \<0.001                 55.5
  Cancer-free patients   6    701/729          **1.59 (1.22--2.07)**         0.175                   34.9
  Matching                                                                                           
  Yes                    39   16,541/19,760    **1.09 (1.00--1.19)\***       \<0.001                 51.3
  No                     28   6,551/6,621      **1.24 (1.04**--**1.46)**\*   \<0.001                 71.9
  Sample size                                                                                        
  ≥ 200                  54   22,326/25,482    **1.13 (1.04--1.23)**\*       \<0.001                 66.9
  \< 200                 13   766/899          **1.34 (1.08--1.65)**         0.145                   30.0
  Quality score                                                                                      
  \>10                   23   15,502/19,098    1.05 (0.97--1.14)\*           0.002                   51.8
  ≤10                    44   7,590/7,283      **1.25 (1.08--1.44)**\*       \<0.001                 64.6
  Menopausal status                                                                                  
  Postmenopausal         15   6,786/9,477      1.08 (0.99--1.17)             0.166                   26.2
  Premenopausal          12   1,605/1,830      **1.31 (1.02--1.67)**\*       0.053                   43.6
  Smoking habits                                                                                     
  Current smoker         3    99/135           2.24 (0.67--7.48)\*           0.053                   66.0
  Past smoker            6    832/876          1.45 (0.93--2.26)\*           0.082                   48.9
  Never                  9    1,343/1,569      1.00 (0.84--1.20)             0.150                   33.5

HB: hospital-based studies, PB: population-based studies

No significantly raised BC risk was observed for *GSTP1* IIe105Val polymorphism in pooling all studies. However, significantly increased BC risk was yielded in some subgroup analyses, such as Asians, Indians, hospital-based studies, no matching, and low-quality studies, as shown in [Table 3](#pone.0216147.t003){ref-type="table"}.

10.1371/journal.pone.0216147.t003

###### Meta-analysis of the association of *GSTP1* polymorphism with risk of breast cancer.
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  Variable             Sample size          Val/Val vs. IIe/IIe       IIe/Val vs. IIe/IIe   Val/Val vs. IIe/IIe + IIe/Val   Val/Val + IIe/Val vs. IIe/IIe   Val vs IIe                                                                                                
  -------------------- -------------------- ------------------------- --------------------- ------------------------------- ------------------------------- ----------------------- -------------- ------------------------- -------------- ------------------------- --------------
  Overall              56 (25,331/27,424)   1.06 (0.91--1.25)\*       \<0.001/73.7          1.04 (0.95--1.15)\*             \<0.001/77.2                    1.05 (0.92--1.19)\*     \<0.001/62.3   1.05 (0.95--1.15)\*       \<0.001/80.0   1.05 (0.97--1.14)\*       \<0.001/83.7
  Ethnicity                                                                                                                                                                                                                                                           
  African              3 (776/769)          0.86 (0.64--1.15)         0.321/12.1            0.91 (0.72--1.15)               0.627/0.0                       0.89 (0.71--1.12)       0.445/0.0      0.89 (0.71--1.12)         0.445/0.0      0.93 (0.81--1.07)         0.328/10.4
  Asian                12 (6,473/7,307)     **1.30 (1.08--1.57)**     0.619/0.0             1.15 (0.99--1.35)\*             0.012/63.5                      **1.25 (1.04--1.51)**   0.574/0.0      **1.12 (1.04--1.20)**     0.120/33.8     **1.12 (1.05--1.19)**     0.107/42.6
  Caucasian            26 (13,015/14,246)   0.96 (0.76--1.21)\*       \<0.001/80.7          0.99 (0.86--1.15)\*             \<0.001/83.2                    0.96 (0.80--1.16)\*     \<0.001/70.8   0.99 (0.85--1.16)\*       \<0.001/86.6   1.00 (0.89--1.13)\*       \<0.001/87.8
  Indian               6 (1,357/1,552)      **1.58 (1.01--2.47)**\*   0.039/57.2            1.20 (0.92--1.56)\*             0.042/56.6                      **1.45 (1.14--1.85)**   0.164/36.4     1.27 (0.94--1.71)\*       0.006/69.0     1.24 (0.97--1.57)\*       0.003/72.5
  Source of controls                                                                                                                                                                                                                                                  
  HB                   18 (4,817/4,072)     1.11 (0.93--1.31)         0.295/13.9            **1.14 (1.01--1.30)**\*         0.090/34.0                      1.06 (0.90--1.25)       0.316/12.0     **1.11 (1.01--1.21)**     0.118/29.3     1.10 (0.99--1.21)         0.082/35.1
  PB                   23 (17,477/20,320)   1.03 (0.80--1.32)\*       \<0.001/86.4          0.99 (0.86--1.15)\*             \<0.001/87.0                    1.03 (0.85--1.26)\*     \<0.001/79.2   1.02 (0.88--1.18)\*       \<0.001/89.5   1.02 (0.88--1.18)\*       \<0.001/91.2
  Type of controls                                                                                                                                                                                                                                                    
  Healthy women        23 (9,350/10,033)    1.11 (0.73--1.68)\*       \<0.001/85.9          1.06 (0.84--1.32)\*             \<0.001/88.8                    1.06 (0.77--1.47)\*     \<0.001/77.2   1.04 (0.83--1.30)\*       \<0.001/89.9   1.06 (0.86--1.30)\*       \<0.001/92.2
  Cancer-free women    28 (14,378/16,163)   1.07 (0.93--1.24)\*       0.004/48.4            1.03 (0.95--1.11)\*             0.028/38.2                      1.07 (0.94--1.21)\*     0.015/42.0     1.04 (0.97--1.12)\*       0.010/42.6     1.04 (0.98--1.12)\*       \<0.001/55.5
  Matching                                                                                                                                                                                                                                                            
  Yes                  26 (14,158/16,510)   0.94 (0.75--1.17)\*       \<0.001/79.1          0.91 (0.79--1.06)\*             \<0.001/83.3                    0.97 (0.82--1.15)\*     \<0.001/68.9   0.94 (0.82--1.08)\*       \<0.001/85.5   0.95 (0.85--1.07)\*       \<0.001/87.4
  No                   30 (11,173/10,914)   1.22 (0.97--1.53)\*       \<0.001/63.6          **1.18 (1.06--1.31)**\*         \<0.001/56.1                    1.14 (0.94--1.38)\*     0.001/52.9     **1.16 (1.04--1.30)**\*   \<0.001/65.1   **1.15 (1.04--1.27)\***   \<0.001/73.8
  Sample size                                                                                                                                                                                                                                                         
  ≥ 200                47 (24,759/26,931)   1.07 (0.91--1.26)\*       \<0.001/76.9          1.03 (0.94--1.14)\*             \<0.001/80.2                    1.05 (0.92--1.20)\*     \<0.001/66.5   1.04 (0.95--1.15)\*       \<0.001/82.9   1.05 (0.96--1.14)\*       \<0.001/85.9
  \< 200               9 (572/493)          1.02 (0.62--1.66)         0.581/0.0             1.22 (0.91--1.63)               0.888/0.0                       0.94 (0.60--1.49)       0.603/0.0      1.11 (0.86--1.45)         0.782/0.0      1.09 (0.88--1.34)         0.649/0.0
  Quality score                                                                                                                                                                                                                                                       
  \>10                 30 (21,061/23,195)   1.01 (0.82--1.24)\*       \<0.001/82.5          0.98 (0.87--1.11)\*             \<0.001/85.6                    1.02 (0.87--1.20)\*     \<0.001/73.0   1.00 (0.88--1.13)\*       \<0.001/87.7   1.00 (0.90--1.12)\*       \<0.001/89.6
  ≤10                  26 (4,270/4,229)     1.17 (0.93--1.45)\*       0.041/37.3            **1.15 (1.04--1.27)**           0.464/0.0                       1.08 (0.89--1.32)\*     0.073/32.3     **1.12 (1.03--1.23)**     0.121/25.2     **1.12 (1.01--1.24)**\*   0.008/47.0
  Menopausal status                                                                                                                                                                                                                                                   
  Postmenopausal       10 (3,448/3,676)     1.06 (0.56--2.00)\*       \<0.001/82.2          0.87 (0.63--1.20)\*             \<0.001/83.0                    1.16 (0.71--1.89)\*     \<0.001/71.3   0.90 (0.67--1.22)\*       \<0.001/85.2   1.00 (0.76--1.31)\*       \<0.001/87.2
  Premenopausal        15 (8,493/11,040)    0.79 (0.52--1.21)\*       \<0.001/88.0          0.96 (0.75--1.23)\*             \<0.001/82.8                    0.82 (0.58--1.15)\*     \<0.001/82.8   0.95 (0.75--1.19)\*       \<0.001/91.2   0.95 (0.77--1.18)\*       \<0.001/93.1
  HWE                                                                                                                                                                                                                                                                 
  Yes                  40 (15,958/15,474)   1.11 (0.95--1.28)\*       \<0.001/59.4          1.07 (0.98--1.17)\*             \<0.001/59.8                    1.07 (0.95--1.21)\*     0.001/46.4     1.09 (0.99--1.20)\*       \<0.001/70.6   1.08 (0.99--1.17)\*       \<0.001/75.3
  No                   8 (8,561/10,766)     0.85 (0.49--1.46)\*       \<0.001/91.9          0.90 (0.66--1.22)\*             \<0.001/87.0                    0.89 (0.58--1.36)\*     \<0.001/87.0   0.89 (0.64--1.23)\*       \<0.001/94.7   0.92 (0.71--1.19)\*       \<0.001/94.7

HB: hospital-based studies, PB: population-based studies, HWE: Hardy-Weinberg equilibrium

The pooled estimates showed an significant association between the combined effects of both *GSTM1* and *GSTT1* null genotypes on BC risk (*− + vs*. *+ +*: OR = 1.18, 95% CI = 1.03--1.35, *− − vs*. *+ +*: OR = 1.65, 95% CI = 1.31--2.07, (*− +*) *+* (*+ −*) *vs*. *+ +*: OR = 1.17, 95% CI = 1.05--1.30, (*− +*) *+* (*+ −*) + (*− −*) *vs*. *+ +*: OR = 1.27, 95% CI = 1.12--1.43, *− − vs*. (*− +*) *+* (*+ −*) + (*+ +*): OR = 1.41, 95% CI = 1.19--1.68) across overall analysis. In addition, a significantly increased BC risk was observed in all subgroup analyses, as shown in [Table 4](#pone.0216147.t004){ref-type="table"}.

10.1371/journal.pone.0216147.t004

###### Meta-analysis of the combined effects of *GSTM1* present/null and *GSTT1* present/null on breast cancer risk.

![](pone.0216147.t004){#pone.0216147.t004g}

  -------------------- -------------------- ------------------------- ------------------------------- ------------------------------- --------------- ------------------------- --------------
  Variable             N (Case/Control)     \+ − vs. + +              − + vs. + +                     − − vs. + +                                                               
  OR (95% CI)          *P*~h~/*I*^2^        OR (95% CI)               *P*~h~/*I*^2^                   OR (95% CI)                     *P*~h~/*I*^2^                             
  Overall              31 (10,497/10,242)   1.04 (0.90--1.21)\*       0.069/34.7                      **1.18 (1.03--1.35)**\*         0.001/58.6      **1.65 (1.31--2.07)**\*   \<0.001/73.8
  Ethnicity                                                                                                                                                                     
  Asian                6 (1,897/2,592)      1.11 (0.90--1.36)         0.628/0.0                       1.05 (0.86--1.28)               0.386/1.3       **2.06 (1.10--3.84)**\*   \<0.001/84.4
  Caucasian            12 (3,749/2,802)     1.06 (0.74--1.53)\*       0.039/54.7                      1.19 (0.96--1.48)\*             0.025/56.2      **1.93 (1.31--2.83)**\*   0.001/67.2
  Indian               3 (671/906)          1.05 (0.77--1.45)         0.943/0.0                       **1.70 (1.09--2.64)**\*         0.120/52.9      2.12 (0.91--4.97)\*       0.091/58.3
  Source of controls                                                                                                                                                            
  HB                   8 (1,192/1,644)      1.37 (0.99--1.89)         0.409/0.0                       0.99 (0.78--1.25)               0.856/0.0       **1.58 (1.21--2.06)**     0.758/0.0
  PB                   10 (5,677/5,473)     0.92 (0.80--1.05)         0.200/29.9                      **1.26 (1.01--1.56)**\*         \<0.001/77.9    **1.40 (1.08--1.82)**\*   0.003/65.5
  Type of controls                                                                                                                                                              
  Healthy women        12 (2,366/2,782)     1.12 (0.88--1.43)         0.192/30.9                      1.30 (0.99--1.70)\*             0.047/50.8      **2.05 (1.28--3.26)**\*   \<0.001/70.2
  Cancer-free women    12 (5,753/5,408)     0.91 (0.80--1.25)         0.248/22.0                      1.13 (0.94--1.35)\*             0.004/64.8      **1.68 (1.23--2.29)**\*   \<0.001/74.9
  Patients             4 (505/640)          **1.74 (1.03--2.95)**     --                              1.03 (0.72--1.48)               --              1.32 (0.80--2.18)         --
  Sample size                                                                                                                                                                   
  ≥ 200                25 (10,181/9,942)    1.06 (0.91--1.24)\*       0.049/39.3                      **1.18 (1.03--1.36)**\*         \<0.001/62.7    **1.56 (1.24--1.96)**\*   \<0.001/74.7
  \< 200               5 (309/453)          0.64 (0.28--1.45)         0.973/0.0                       1.37 (0.63--2.95)               0.933/0.0       **3.82 (1.76--8.29)**     0.449/0.0
  Quality score                                                                                                                                                                 
  \>10                 13 (7,183/7,124)     0.98 (0.80--1.20)\*       0.056/49.0                      1.03 (0.93--1.13)               0.291/17.6      **1.23 (1.01--1.50)**\*   0.007/58.6
  ≤10                  18 (3,307/3,222)     1.12 (0.92--1.36)         0.276/17.6                      **1.36 (1.07--1.72)**\*         0.002/62.3      **2.45 (1.58--3.81)**\*   \<0.001/72.9
  Matching                                                                                                                                                                      
  Yes                  17 (6,048/6,558)     0.97 (0.86--1.10)         0.187/26.2                      1.04 (0.95--1.14)               0.542/0.0       **1.33 (1.10--1.60)\***   0.065/40.3
  No                   12 (4,241/3,414)     1.19 (0.84--1.67)\*       0.070/48.5                      **1.47 (1.07--2.01)**\*         \<0.001/74.8    **2.30 (1.38--3.82)**\*   \<0.001/85.0
  Menopausal status                                                                                                                                                             
  Postmenopausal       7 (1,916/2,268)      0.88 (0.55--1.41)\*       0.077/61.0                      1.01 (0.84--1.21)               0.997/0.0       **1.49 (1.14--1.94)**     0.498/0.0
  Premenopausal        6 (981/1,185)        1.02 (0.44--2.35)\*       0.056/65.4                      1.01 (0.77--1.32)               0.934/0.0       1.18 (0.91--1.53)         0.143/39.4
  Variable             Sample size          (+ −) + (− +) vs. + +     (+ −) + (− +) + (− −) vs. + +   − − vs. (+ +) + (+ −) + (− +)                                             
  OR (95% CI)          *P*~h~/*I*^2^        OR (95% CI)               *P*~h~/*I*^2^                   OR (95% CI)                     *P*~h~/*I*^2^                             
  Overall              31 (10,497/10,242)   **1.17 (1.05--1.30)**\*   \<0.001/55.9                    **1.27 (1.12--1.43)**           \<0.001/68.0    **1.41 (1.19--1.68)**\*   \<0.001/65.9
  Ethnicity                                                                                                                                                                     
  Asian                6 (1,897/2,592)      1.13 (0.96--1.33)         0.300/18.0                      1.40 (0.99--1.98)\*             0.012/68.8      **1.53 (1.01--2.31)**\*   \<0.001/82.5
  Caucasian            12 (3,749/2,802)     1.23 (0.99--1.51)\*       0.002/64.9                      **1.36 (1.10--1.68)\***         \<0.001/71.1    **1.61 (1.22--2.12)\***   0.037/46.7
  Indian               3 (671/906)          **1.48 (1.19--1.84)**\*   0.204/37.1                      **1.54 (1.02--2.32)**\*         0.082/60.0      1.85 (0.85--4.01)\*       0.106/55.4
  Source of controls                                                                                                                                                            
  HB                   8 (1,192/1,644)      1.15 (0.94--1.40)         0.673/0.0                       **1.22 (1.01--1.47)**           0.569/0.0       **1.42 (1.16--1.75)**     0.376/7.0
  PB                   10 (5,677/5,473)     1.17 (0.99--1.38)\*       0.001/71.2                      **1.23 (1.04--1.45)**\*         \<0.001/73.7    **1.22 (1.01--1.49)**\*   0.021/54.0
  Type of controls                                                                                                                                                              
  Healthy women        12 (2,366/2,782)     **1.31 (1.04--1.65)**\*   0.012/57.2                      **1.43 (1.10--1.85)**\*         0.001/67.8      **1.67 (1.25--2.23)**\*   0.030/49.7
  Cancer-free women    12 (5,753/5,408)     1.10 (0.95--1.29)\*       0.011/58.0                      **1.23 (1.04--1.46)**\*         \<0.001/70.6    **1.46 (1.13--1.88)**\*   \<0.001/72.9
  Patients             4 (505/640)          1.16 (0.83--1.64)         --                              1.20 (0.86--1.66)               --              1.13 (0.78--1.64)         0.213/33.2
  Sample size                                                                                                                                                                   
  ≥ 200                25 (10,181/9,942)    **1.15 (1.04--1.28)**\*   0.001/55.7                      **1.25 (1.11--1.41)**\*         \<0.001/69.3    **1.34 (1.13--1.60)**\*   \<0.001/68.0
  \< 200               5 (309/453)          1.68 (0.57--4.94)\*       0.057/65.0                      1.60 (0.62--4.12)\*             0.051/61.5      **2.77 (1.61--4.78)**\*   0.697/0.0
  Quality score                                                                                                                                                                 
  \>10                 13 (7,183/7,124)     1.03 (0.96--1.12)         0.265/18.8                      1.06 (0.99--1.14)               0.105/35.7      1.16 (0.97--1.37)\*       0.005/59.0
  ≤10                  18 (3,307/3,222)     **1.36 (1.09--1.69)**\*   0.001/62.4                      **1.53 (1.19--1.96)**\*         \<0.001/72.9    **1.82 (1.36--2.43)**\*   0.002/57.7
  Matching                                                                                                                                                                      
  Yes                  17 (6,048/6,558)     1.04 (0.95--1.13)         0.399/4.7                       1.07 (0.98--1.16)               0.231/20.4      **1.25 (1.05--1.48)**\*   0.018/46.5
  No                   12 (4,241/3,414)     **1.35 (1.09--1.67)**\*   \<0.001/71.2                    **1.51 (1.20--1.91)**\*         \<0.001/80.0    **1.81 (1.24--2.62)**\*   \<0.001/78.4
  Menopausal status                                                                                                                                                             
  Postmenopausal       7 (1,916/2,268)      1.05 (0.91--1.22)         0.216/30.9                      1.14 (0.99--1.31)               0.216/29.2      **1.25 (1.02--1.53)**     0.247/23.9
  Premenopausal        6 (981/1,185)        1.01 (0.81--1.23)         0.495/0.0                       1.01 (0.83--1.24)               0.523/0.0       1.18 (0.91--1.53)         0.143/39.4
  -------------------- -------------------- ------------------------- ------------------------------- ------------------------------- --------------- ------------------------- --------------

HB: hospital-based studies, PB: population-based studies; + −: *GSTM1* present/*GSTT1* null; − +: *GSTM1* null/*GSTT1* present; − −: *GSTM1* null/*GSTT1* null; + +: *GSTM1* present/*GSTT1* present

[Table 5](#pone.0216147.t005){ref-type="table"} lists the results of the combined effects of both *GSTM1* present/null and *GSTP1* IIe105Val polymorphisms on BC risk. Overall, a significant association was found between the combined effects of *GSTM1* present/null and *GSTP1* IIe105Val polymorphisms on BC risk (*GSTM1* null/*GSTP1* IIe/IIe + *GSTM1* present/*GSTP1* Val\* vs. *GSTM1* present/*GSTP1* IIe/IIe: OR = 1.14, 95% CI = 1.00--1.31, *GSTM1* null/*GSTP1* Val\* vs. *GSTM1* present/*GSTP1* IIe/IIe: OR = 1.58, 95% CI = 1.21--2.06, all risk genotypes vs. *GSTM1* present/*GSTP1* IIe/IIe: OR = 1.28, 95% CI = 1.08--1.52, *GSTM1* null/*GSTP1* Val\* vs. (*GSTM1* null/*GSTP1* IIe/IIe + *GSTM1* present/*GSTP1* Val\* + *GSTM1* present/*GSTP1* IIe/IIe): OR = 1.40, 95% CI = 1.12--1.75). Furthermore, a statistically significant association was also observed in a slice of subgroups, for example, Asians, Caucasians, Indians, no population-based studies, population-based studies, healthy women, cancer-free women, large-sized studies, small-sized studies, high-quality studies, low-quality studies, no matching studies, and controls in HWE studies.

10.1371/journal.pone.0216147.t005

###### Meta-analysis of the combined effects of *GSTM1* present/null and *GSTP1* IIe105Val on breast cancer risk.

![](pone.0216147.t005){#pone.0216147.t005g}

  -------------------- ------------------------------- ------------------------------------------------------------------------------ ---------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------- ------------------------- --------------
  **Variable**         **Sample size**                 ***GSTM1* null/ *GSTP1* IIe/IIe vs. *GSTM1* present/ *GSTP1* IIe/IIe**         ***GSTM1* present/*GSTP1* Val** ^**1**^ **vs. *GSTM1* present/ *GSTP1* IIe/IIe**   **(*GSTM1* null/ *GSTP1* IIe/IIe + *GSTM1* present/*GSTP1* Val** ^**1**^**) vs. *GSTM1* present/ *GSTP1* IIe/IIe**                                                                                                   
  **OR (95% CI)**      ***P***~**h**~**/*I***^**2**^   **OR (95% CI)**                                                                ***P***~**h**~**/*I***^**2**^                                                      **OR (95% CI)**                                                                                                                                            ***P***~**h**~**/*I***^**2**^                             
  Overall              15 (6,272/6,739)                1.10 (0.99--1.22)                                                              0.330/11.5                                                                         1.08 (0.92--1.27)                                                                                                                                          0.030/47.1                      **1.14 (1.00--1.31)**\*   0.009/52.8
  Ethnicity                                                                                                                                                                                                                                                                                                                                                                                                                                   
  Asian                3 (1,934/2,486)                 0.99 (0.86--1.16)                                                              0.483/0.0                                                                          1.07 (0.89--1.28)                                                                                                                                          0.620/0.0                       1.02 (0.89--1.17)         0.485/0.0
  Caucasian            6 (1,148/1,194)                 **1.37 (1.03--1.83)**                                                          0.709/0.0                                                                          1.41 (0.90--2.22)\*                                                                                                                                        0.069/54.0                      **1.60 (1.29--1.98)**     0.286/19.5
  Indian               2 (649/896)                     1.25 (0.64--2.41)\*                                                            0.064/70.9                                                                         1.05 (0.63--1.74)\*                                                                                                                                        0.049/74.2                      1.10 (0.62--1.94)\*       0.017/82.4
  Source of controls                                                                                                                                                                                                                                                                                                                                                                                                                          
  NPB                  8 (2,359/2,474)                 1.14 (0.91--1.43)                                                              0.306/16.7                                                                         1.02 (0.82--1.25)                                                                                                                                          0.150/38.4                      1.20 (0.94--1.54)\*       0.009/62.7
  PB                   7 (3,913/4,265)                 1.09 (0.97--1.23)                                                              0.285/19.0                                                                         1.12 (0.91--1.39)\*                                                                                                                                        0.025/58.5                      1.07 (0.96--1.19)         0.106/42.8
  Type of controls                                                                                                                                                                                                                                                                                                                                                                                                                            
  Healthy women        8 (2,072/2,859)                 1.13 (0.95--1.34)                                                              0.446/0.0                                                                          1.14 (0.83--1.57)\*                                                                                                                                        0.012/63.2                      1.27 (0.98--1.64)\*       0.005/65.5
  Cancer-free women    4 (2,614/2,698)                 1.17 (0.92--1.50)\*                                                            0.097/52.5                                                                         1.07 (0.92--1.25)                                                                                                                                          0.411/0.0                       1.07 (0.94--1.22)         0.213/33.2
  Sample size                                                                                                                                                                                                                                                                                                                                                                                                                                 
  ≥ 200                13 (6122/6529)                  1.08 (0.97--1.20)                                                              0.469/0.0                                                                          1.09 (0.92--1.29)\*                                                                                                                                        0.025/51.0                      1.14 (0.99--1.31)\*       0.005/58.0
  \< 200               2 (150/210)                     **2.07 (1.09**--**3.94)**                                                      0.793/0.0                                                                          0.90 (0.38--2.16)\*                                                                                                                                        0.150/51.7                      1.31 (0.78--2.22)         0.433/0.0
  Quality score                                                                                                                                                                                                                                                                                                                                                                                                                               
  \>10                 9 (5,008/5,197)                 1.07 (0.96--1.20)                                                              0.314/14.8                                                                         1.09 (0.89--1.33)\*                                                                                                                                        0.033/54.0                      1.07 (0.95--1.20)         0.177/30.2
  ≤10                  6 (1,264/1,542)                 1.27 (0.97--1.65)                                                              0.394/2.2                                                                          1.05 (0.84--1.32)                                                                                                                                          0.113/46.4                      1.35 (0.94--1.93)\*       0.009/67.4
  Matching                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Yes                  8 (3,947/4,762)                 1.04 (0.92--1.16)                                                              0.702/0.0                                                                          0.96 (0.85--1.09)                                                                                                                                          0.614/0.0                       0.99 (0.90--1.10)         0.567/0.0
  No                   7 (2,325/1,977)                 **1.48 (1.14--1.91)**                                                          0.605/0.0                                                                          1.43 (0.98--2.10)                                                                                                                                          0.071/53.6                      **1.46 (1.14--1.87)**\*   0.038/55.1
  HWE                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Yes                  9 (3767/4276)                   **1.16 (1.02--1.33)**                                                          0.573/0.0                                                                          1.13 (0.90--1.42)                                                                                                                                          0.007/64.0                      1.23 (0.99--1.51)\*       0.002/68.1
  No                   2 (193/236)                     1.61 (0.90--2.88)                                                              0.394/0.0                                                                          1.31 (0.75--2.28)                                                                                                                                          0.835/0.0                       1.43 (0.88--2.32)         0.639/0.0
  **Variable**         **Sample size**                 ***GSTM1* null/ GSTP1 Val** ^**1**^ **vs. *GSTM1* present/ *GSTP1* IIe/IIe**   **all risk genotypes vs. *GSTM1* present/ *GSTP1* IIe/IIe**                        ***GSTM1* null/ GSTP1 Val** ^**1**^ **vs. (*GSTM1* null/ *GSTP1* IIe/IIe + *GSTM1* present/*GSTP1* Val** ^**1**^ **+ *GSTM1* present/ *GSTP1* IIe/IIe)**                                                             
  **OR (95% CI)**      ***P***~**h**~**/*I***^**2**^   **OR (95% CI)**                                                                ***P***~**h**~**/*I***^**2**^                                                      **OR (95% CI)**                                                                                                                                            ***P***~**h**~**/*I***^**2**^                             
  Overall              15 (6,272/6,739)                **1.58 (1.21--2.06)**\*                                                        \<0.001/82.2                                                                       **1.28 (1.08--1.52)**\*                                                                                                                                    \<0.001/73.5                    **1.40 (1.12--1.75)**\*   \<0.001/82.4
  Ethnicity                                                                                                                                                                                                                                                                                                                                                                                                                                   
  Asian                3 (1,934/2,486)                 **1.23 (1.03--1.46)**                                                          0.604/0.0                                                                          1.07 (0.94--1.22)                                                                                                                                          0.555/0.0                       **1.21 (1.04--1.41)**     0.493/0.0
  Caucasian            6 (1,148/1,194)                 **2.11 (1.21--3.66)\***                                                        \<0.001/79.6                                                                       **1.77 (1.26--2.48)**\*                                                                                                                                    0.034/58.6                      1.55 (0.94--2.56)\*       \<0.001/85.5
  Indian               2 (649/896)                     2.14 (0.86--5.34)\*                                                            0.003/89.1                                                                         1.36 (0.63--2.97)\*                                                                                                                                        \<0.001/91.8                    **2.02 (1.14--3.59)**\*   0.032/78.3
  Source of controls                                                                                                                                                                                                                                                                                                                                                                                                                          
  NPB                  8 (2,359/2,474)                 **1.41 (1.17--1.70)**                                                          0.376/7.0                                                                          **1.24 (1.01--1.54)**\*                                                                                                                                    0.029/55.1                      **1.19 (1.02--1.38)**     0.146/35.3
  PB                   7 (3,913/4,265)                 **1.74 (1.10--2.76)**\*                                                        \<0.001/91.5                                                                       **1.33 (1.01--1.74)**\*                                                                                                                                    \<0.001/83.9                    **1.58 (1.08--2.29)**\*   \<0.001/91.3
  Type of controls                                                                                                                                                                                                                                                                                                                                                                                                                            
  Healthy women        8 (2,072/2,859)                 **1.86 (1.32--2.62)**\*                                                        0.001/72.7                                                                         **1.44 (1.10--1.89)**\*                                                                                                                                    0.001/72.6                      1.25 (0.80--1.96)\*       \<0.001/90.1
  Cancer-free women    4 (2,614/2,698)                 1.39 (0.81--2.37)\*                                                            \<0.001/90.0                                                                       1.23 (0.90--1.68)\*                                                                                                                                        0.002/80.4                      **1.57 (1.15--2.15)**\*   \<0.001/77.9
  Sample size                                                                                                                                                                                                                                                                                                                                                                                                                                 
  ≥ 200                13 (6,122/6,529)                **1.52 (1.15--2.01)**\*                                                        \<0.001/83.9                                                                       **1.26 (1.05--1.50)**\*                                                                                                                                    \<0.001/76.2                    **1.35 (1.07--1.70)**\*   \<0.001/84.1
  \< 200               2 (1,50/2,10)                   **2.36 (1.32--4.22)**                                                          0.656/0.0                                                                          **1.64 (1.01--2.66)**                                                                                                                                      0.470/0.0                       **1.99 (1.24--3.20)**     0.986/0.0
  Quality score                                                                                                                                                                                                                                                                                                                                                                                                                               
  \>10                 9 (5,008/5,197)                 **1.61 (1.11--2.35)**\*                                                        \<0.001/88.7                                                                       **1.23 (1.00--1.52)**                                                                                                                                      \<0.001/79.0                    **1.51 (1.11--2.06)**\*   \<0.001/88.5
  ≤10                  6 (1,264/1,542)                 **1.47 (1.18--1.83)**                                                          0.236/26.5                                                                         **1.39 (1.02--1.89)**                                                                                                                                      0.026/60.7                      1.21 (0.94--1.57)         0.094/46.9
  Matching                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Yes                  8 (3,947/4,762)                 1.16 (0.93--1.43)\*                                                            0.014/60.2                                                                         1.03 (0.93--1.13)                                                                                                                                          0.252/22.3                      1.16 (0.95--1.41)         0.004/66.1
  No                   7 (2,325/1,977)                 **2.30 (1.44--3.69)**\*                                                        \<0.001/81.2                                                                       **1.74 (1.26--2.39)**\*                                                                                                                                    \<0.001/76.6                    **1.76 (1.13--2.76)**\*   \<0.001/86.6
  HWE                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Yes                  9 (3,767/4,276)                 **1.74 (1.17--2.60)**\*                                                        \<0.001/88.8                                                                       **1.41 (1.08--1.83)\***                                                                                                                                    \<0.001/82.7                    1.47 (1.06--2.04)\*       \<0.001/88.8
  No                   2 (193/236)                     1.56 (0.56--4.33)\*                                                            0.061/71.6                                                                         1.44 (0.92--2.26)                                                                                                                                          0.246/25.6                      1.23 (0.50--3.00)\*       0.041/76.1
  -------------------- ------------------------------- ------------------------------------------------------------------------------ ---------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------- ------------------------- --------------

PB: population-based studies, HWE: Hardy-Weinberg equilibrium; NPB: no population-based studies; Val ^1^:IIe/Val + Val/Val

[Table 6](#pone.0216147.t006){ref-type="table"} lists the results of the combined effects of both *GSTT1* present/null and *GSTP1* IIe105Val polymorphisms on BC risk. The results showed an raised BC risk (*GSTT1* null/*GSTP1* Val\* vs. *GSTT1* present/*GSTP1* IIe/IIe: OR = 1.44, 95% CI = 1.10--1.88, all risk genotypes vs. *GSTT1* present/*GSTP1* IIe/IIe: OR = 1.23, 95% CI = 1.03--1.48, *GSTT1* null/*GSTP1* Val\* vs. (*GSTT1* null/*GSTP1* IIe/IIe + *GSTT1* present/*GSTP1* Val\* + *GSTT1* present/*GSTP1* IIe/IIe): OR = 1.26, 95% CI = 1.03--1.54) in all eligible studies. Analyses of subgroups also showed an increased BC risk in Caucasians, Indians, no population-based studies, population-based studies, healthy women, large-sized studies, small-sized studies, high-quality studies, low-quality studies, and no matching studies.

10.1371/journal.pone.0216147.t006

###### Meta-analysis of the combined effects of *GSTT1* present/null and *GSTP1* IIe105Val on breast cancer risk.

![](pone.0216147.t006){#pone.0216147.t006g}

  ---------------------------------------------------------------------------------------------------------- ------------------------------- ------------------------------------------------------------------------------ ---------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------- ------------------------------------------------------------ --------------
  **Variable**                                                                                               **Sample size**                 ***GSTT1* null/ *GSTP1* IIe/IIe vs. *GSTT1* present/ *GSTP1* IIe/IIe**         ***GSTT1* present/*GSTP1* Val** ^**1**^ **vs. *GSTT1* present/ *GSTP1* IIe/IIe**   **(*GSTT1* null/*GSTP1* IIe/IIe + *GSTT1* present/*GSTP1* Val** ^**1**^**) vs. *GSTT1* present/ *GSTP1* IIe/IIe**                                                                                                                                       
  **OR (95% CI)**                                                                                            ***P***~**h**~**/*I***^**2**^   **OR (95% CI)**                                                                ***P***~**h**~**/*I***^**2**^                                                      **OR (95% CI)**                                                                                                                                            ***P***~**h**~**/*I***^**2**^                                                                
  Overall                                                                                                    13 (5,413/5,567)                1.07 (0.94--1.22)                                                              0.121/33.6                                                                         1.22 (0.97--1.53)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     \<0.001/77.1                    1.18 (0.99--1.40)[\*](#t006fn001){ref-type="table-fn"}       \<0.001/71.9
  Ethnicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Asian                                                                                                      2 (1,321/1,610)                 1.04 (0.87--1.25)                                                              0.458/0.0                                                                          1.14 (0.92--1.42)                                                                                                                                          0.388/0.0                       1.07 (0.91--1.27)                                            0.865/0.0
  Caucasian                                                                                                  5 (912/885)                     1.22 (0.65--2.29)[\*](#t006fn001){ref-type="table-fn"}                         0.051/57.6                                                                         1.45 (0.79--2.66)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     \<0.001/84.4                    1.50 (0.86--2.60)[\*](#t006fn001){ref-type="table-fn"}       \<0.001/82.6
  Indian                                                                                                     2 (649/896)                     0.80 (0.54--1.18)                                                              0.540/0.0                                                                          1.16 (0.62--2.17)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     0.007/86.2                      1.09 (0.63--1.88)[\*](#t006fn001){ref-type="table-fn"}       0.014/83.4
  Source of controls                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  NPB                                                                                                        7 (2,105/2,165)                 1.12 (0.75--1.68)[\*](#t006fn001){ref-type="table-fn"}                         0.049/55.0                                                                         0.98 (0.82--1.18)                                                                                                                                          0.845/0.0                       1.00 (0.87--1.15)                                            0.768/0.0
  PB                                                                                                         6 (3,308/3,402)                 1.08 (0.93--1.25)                                                              0.365/8.0                                                                          **1.48 (1.02--2.15)**[\*](#t006fn001){ref-type="table-fn"}                                                                                                 \<0.001/88.5                    **1.40 (1.02--1.93)**[\*](#t006fn001){ref-type="table-fn"}   \<0.001/86.6
  Type of controls                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Healthy women                                                                                              6 (1,223/1,674)                 1.05 (0.68--1.64)[\*](#t006fn001){ref-type="table-fn"}                         0.046/55.6                                                                         1.31 (0.80--2.14)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     \<0.001/84.0                    1.35 (0.87--2.08)[\*](#t006fn001){ref-type="table-fn"}       \<0.001/82.8
  Cancer-free women                                                                                          4 (2,622/2,711)                 1.05 (0.89--1.23)                                                              0.694/0.0                                                                          1.15 (0.92--1.45)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     0.062/59.0                      1.09 (0.97--1.22)                                            0.286/20.7
  Sample size                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  ≥ 200                                                                                                      11 (5,263/5,357)                1.05 (0.92--1.20)                                                              0.381/6.6                                                                          1.23 (0.96--1.58)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     \<0.001/81.2                    1.17 (0.97--1.41)[\*](#t006fn001){ref-type="table-fn"}       \<0.001/76.2
  \< 200                                                                                                     2 (150/210)                     1.88 (0.51--6.92)[\*](#t006fn001){ref-type="table-fn"}                         0.050/74.1                                                                         1.11 (0.65--1.90)                                                                                                                                          0.594/0.0                       1.33 (0.81--2.19)                                            0.685/0.0
  Quality score                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  \>10                                                                                                       8 (4,385/4,334)                 1.09 (0.95--1.26)                                                              0.461/0.0                                                                          1.39 (0.99--1.95)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     \<0.001/86.4                    **1.28 (1.00--1.62)**                                        \<0.001/81.9
  ≤10                                                                                                        5 (1,028/1,233)                 1.12 (0.66--1.93)[\*](#t006fn001){ref-type="table-fn"}                         0.032/62.2                                                                         0.99 (0.82--1.20)                                                                                                                                          0.744/0.0                       0.99 (0.83--1.19)                                            0.563/0.0
  Matching                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Yes                                                                                                        7 (3,342/3,899)                 1.09 (0.95--1.26)                                                              0.335/12.4                                                                         1.00 (0.84--1.19)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     0.091/45.0                      1.01 (0.88--1.18)                                            0.126/39.8
  No                                                                                                         6 (2,071/1,668)                 1.08 (0.63--1.86)[\*](#t006fn001){ref-type="table-fn"}                         0.053/57.2                                                                         1.63 (0.98--2.71)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     \<0.001/82.9                    1.44 (0.99--2.11)[\*](#t006fn001){ref-type="table-fn"}       \<0.001/81.9
  HWE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Yes                                                                                                        7 (2,926/3,104)                 1.04 (0.85--1.26)                                                              0.193/30.8                                                                         1.35 (0.96--1.90)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     \<0.001/87.1                    1.30 (0.96--1.78)[\*](#t006fn001){ref-type="table-fn"}       \<0.001/85.3
  No                                                                                                         2 (193/236)                     1.18 (0.62--2.24)                                                              0.574/0.0                                                                          1.02 (0.65--1.61)                                                                                                                                          0.481/0.0                       1.05 (0.68--1.61)                                            0.725/0.0
  Only studies with high quality, matching, HWE, and genotyping examination done bindly or quality control                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Yes                                                                                                        3 (1,643/1,661)                 1.29 (0.99--1.67)                                                              0.350/4.7                                                                          1.06 (0.75--1.51)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     0.023/73.5                      1.11 (0.79--1.57)[\*](#t006fn001){ref-type="table-fn"}       0.021/74.2
  **Variable**                                                                                               **Sample size**                 ***GSTT1* null/ GSTP1 Val** ^**1**^ **vs. *GSTT1* present/ *GSTP1* IIe/IIe**   **all risk genotypes vs. *GSTT1* present/ *GSTP1* IIe/IIe**                        ***GSTT1* null/ GSTP1 Val** ^**1**^ **vs. (*GSTT1* null/ *GSTP1* IIe/IIe + *GSTT1* present/*GSTP1* Val** ^**1**^ **+ *GSTT1* present/ *GSTP1* IIe/IIe)**                                                                                                
  **OR (95% CI)**                                                                                            ***P***~**h**~**/*I***^**2**^   **OR (95% CI)**                                                                ***P***~**h**~**/*I***^**2**^                                                      **OR (95% CI)**                                                                                                                                            ***P***~**h**~**/*I***^**2**^                                                                
  Overall                                                                                                    13 (5,413/5,567)                **1.44 (1.10--1.88)**[\*](#t006fn001){ref-type="table-fn"}                     \<0.001/68.4                                                                       **1.23 (1.03--1.48)**[\*](#t006fn001){ref-type="table-fn"}                                                                                                 \<0.001/76.3                    **1.26 (1.03--1.54)**[\*](#t006fn001){ref-type="table-fn"}   0.013/52.7
  Ethnicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Asian                                                                                                      2 (1,321/1,610)                 1.34 (0.85--2.11)[\*](#t006fn001){ref-type="table-fn"}                         0.099/63.3                                                                         1.11 (0.95--1.30)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     0.481/0.0                       1.29 (0.83--1.98)[\*](#t006fn001){ref-type="table-fn"}       0.073/68.8
  Caucasian                                                                                                  5 (912/885)                     **2.09 (1.15--3.80)**[\*](#t006fn001){ref-type="table-fn"}                     0.037/60.8                                                                         1.60 (0.92--2.79)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     \<0.001/83.9                    **1.50 (1.11--2.02)**                                        0.358/8.4
  Indian                                                                                                     2 (649/896)                     1.62 (0.92--2.87)[\*](#t006fn001){ref-type="table-fn"}                         0.114/60.0                                                                         1.16 (0.66--2.05)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     0.008/85.6                      **1.55 (1.12--2.15)**                                        0.478/0.0
  Source of controls                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  NPB                                                                                                        7 (2,105/2,165)                 **1.51 (1.18--1.93)**                                                          0.582/0.0                                                                          1.06 (0.92--1.21)                                                                                                                                          0.540/0.0                       **1.48 (1.18--1.85)**                                        0.761/0.0
  PB                                                                                                         6 (3,308/3,402)                 1.36 (0.89--2.09)[\*](#t006fn001){ref-type="table-fn"}                         \<0.001/82.6                                                                       **1.42 (1.02--1.99)**[\*](#t006fn001){ref-type="table-fn"}                                                                                                 \<0.001/88.9                    1.10 (0.83--1.47)[\*](#t006fn001){ref-type="table-fn"}       0.011/66.4
  Type of controls                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Healthy women                                                                                              6 (1,223/1,674)                 **1.85 (1.21--2.82)**[\*](#t006fn001){ref-type="table-fn"}                     0.041/56.8                                                                         1.46 (0.95--2.25)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     \<0.001/84.0                    **1.52 (1.21--1.92)**                                        0.444/0.0
  Cancer-free women                                                                                          4 (2,622/2,711)                 1.21 (0.80--1.82)[\*](#t006fn001){ref-type="table-fn"}                         0.005/76.3                                                                         1.12 (0.93--1.36)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     0.071/57.3                      1.11 (0.80--1.54)[\*](#t006fn001){ref-type="table-fn"}       0.023/68.4
  Sample size                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  ≥ 200                                                                                                      11 (5,263/5,357)                **1.36 (1.03--1.79)**                                                          \<0.001/69.9                                                                       1.21 (0.99--1.47)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     \<0.001/79.4                    1.21 (0.98--1.48)[\*](#t006fn001){ref-type="table-fn"}       0.019/53.1
  \< 200                                                                                                     2 (150/210)                     **2.30 (1.16--4.54)**                                                          0.265/19.4                                                                         1.51 (0.93--2.44)                                                                                                                                          0.558/0.0                       **1.87 (1.05--3.31)**                                        0.272/17.2
  Quality score                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  \> 10                                                                                                      8 (4,385/4,334)                 1.44 (0.99--2.08)[\*](#t006fn001){ref-type="table-fn"}                         \<0.001/78.8                                                                       **1.32 (1.02--1.69)**[\*](#t006fn001){ref-type="table-fn"}                                                                                                 \<0.001/84.8                    1.21 (0.93--1.57)[\*](#t006fn001){ref-type="table-fn"}       \<0.001/65.6
  ≤10                                                                                                        5 (1,028/1,233)                 **1.39 (1.04--1.87)**                                                          0.434/0.0                                                                          1.05 (0.88--1.25)                                                                                                                                          0.406/0.0                       **1.38 (1.06--1.81)**                                        0.632/0.0
  Matching                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Yes                                                                                                        7 (3,342/3,899)                 1.09 (0.85--1.41)[\*](#t006fn001){ref-type="table-fn"}                         0.040/54.5                                                                         1.03 (0.89--1.20)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     0.075/47.6                      1.06 (0.86--1.32)[\*](#t006fn001){ref-type="table-fn"}       0.075/47.6
  No                                                                                                         6 (2,071/1,668)                 **2.12 (1.37--3.28)**[\*](#t006fn001){ref-type="table-fn"}                     0.066/51.6                                                                         **1.54 (1.05--2.28)**[\*](#t006fn001){ref-type="table-fn"}                                                                                                 \<0.001/83.7                    **1.60 (1.25--2.04)**                                        0.461/0.0
  HWE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Yes                                                                                                        7 (2,926/3,104)                 1.38 (0.91--2.10)[\*](#t006fn001){ref-type="table-fn"}                         \<0.001/79.4                                                                       1.33 (0.97--1.84)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     \<0.001/87.3                    1.17 (0.87--1.56)[\*](#t006fn001){ref-type="table-fn"}       0.013/63.0
  No                                                                                                         2 (193/236)                     1.47 (0.75--2.87)                                                              0.829/0.0                                                                          1.10 (0.73--1.68)                                                                                                                                          0.659/0.0                       1.39 (0.78--2.49)                                            0.964/0.0
  Only studies with high quality, matching, HWE, and genotyping examination done bindly or quality control                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Yes                                                                                                        3 (1643/1661)                   0.83 (0.66--1.04)[\*](#t006fn001){ref-type="table-fn"}                         0.125/52.0                                                                         1.08 (0.76--1.53)[\*](#t006fn001){ref-type="table-fn"}                                                                                                     0.015/76.1                      0.82 (0.66--1.02)                                            0.601/0.0
  ---------------------------------------------------------------------------------------------------------- ------------------------------- ------------------------------------------------------------------------------ ---------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------- ------------------------------------------------------------ --------------

\* A random-effect model was used when *P* \< 0.10 and/or I^2^ \> 50%; otherwise, a fixed-effects model was used, PB: population-based studies, HWE: Hardy-Weinberg equilibrium; NPB: no population-based studies; Val ^1^:IIe/Val + Val/Val

Finally, we also performed a pooled analysis to investigate the combined effects of *GSTM1* present/null, *GSTT1* present/null, and *GSTP1* IIe105Val polymorphisms on BC risk. The results indicated that a significantly increased BC risk was found in overall populations ([Table 7](#pone.0216147.t007){ref-type="table"}); respective OR was 1.44 (95% CI = 1.00--2.06) for *GSTM1* null/*GSTT1* null/*GSTP1* IIe/IIe vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe, OR was 1.54 (95% CI = 1.08--2.18) for *GSTM1* null/*GSTT1* present/*GSTP1* Val\* vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe, OR was 1.41 (95% CI = 1.08--1.83) for all two high-risk genotypes vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe, OR was 1.79 (95% CI = 1.19--2.67) for *GSTM1* null/*GSTT1* null/*GSTP1* Val\* vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe, and OR was 1.51 (95% CI = 1.10--2.06) for *GSTM1* null/*GSTT1* null/*GSTP1* Val\* vs. (all one high-risk genotypes + all two high-risk genotypes + *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe). The results of subgroups indicated that significant association was also observed in Caucasians, Indians, no population-based studies, population-based studies, healthy women, large-sized studies, small-sized studies, high-quality studies, low-quality studies, no matching studies, and controls in HWE studies, as shown in [Table 7](#pone.0216147.t007){ref-type="table"}.

10.1371/journal.pone.0216147.t007

###### Meta-analysis of the combined effects of *GSTM1* present/null, *GSTT1* present/null and *GSTP1* present/null on breast cancer risk.

![](pone.0216147.t007){#pone.0216147.t007g}

  ---------------------------------------------------------------------------------------------------------- ------------------------------- -------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------- ------------------------------------------------------------ ------------------------------- ------------------------------------------------------------ ------------
  **Variable**                                                                                               **Sample size**                 ***M1* null/*T1* present/*P1* IIe/IIe vs. *M1* present/*T1* present/*P1* IIe/IIe**     ***M1* present/*T1* null/*P1* IIe/IIe vs. *M1* present/*T1* present/*P1* IIe/IIe**     ***M1* present/*T1* present/*P1* Val** ^**1**^ **vs. *M1* present/*T1* present/*P1* IIe/IIe**   **all one high-risk genotype vs. vs. *M1* present/*T1* present/*P1* IIe/IIe**       **M1 null/T1 null/P1 IIe/IIe vs. *M1* present/*T1* present/*P1* IIe/IIe**                                                                                                                                                                                                                                                                   
  **OR (95% CI)**                                                                                            ***P***~**h**~**/*I***^**2**^   **OR (95% CI)**                                                                        ***P***~**h**~**/*I***^**2**^                                                          **OR (95% CI)**                                                                                 ***P***~**h**~**/*I***^**2**^                                                       **OR (95% CI)**                                                                                                                                   ***P***~**h**~**/*I***^**2**^   **OR (95% CI)**                                              ***P***~**h**~**/*I***^**2**^                                                                
  Overall                                                                                                    13 (5,395/5,544)                1.05 (0.91--1.21)                                                                      0.682/0.0                                                                              0.96 (0.80--1.15)                                                                               0.695/0.0                                                                           1.04 (0.85--1.27)[\*](#t007fn001){ref-type="table-fn"}                                                                                            0.065/41.5                      1.03 (0.92--1.14)                                            0.356/8.9                       **1.44 (1.00--2.06)**[\*](#t007fn001){ref-type="table-fn"}   0.016/52.9
  Ethnicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Asian                                                                                                      2 (1,321/1,610)                 0.87 (0.67--1.13)                                                                      0.342/0.0                                                                              0.96 (0.73--1.26)                                                                               0.768/0.0                                                                           0.91 (0.65--1.26)                                                                                                                                 0.387/0.0                       0.91 (0.72--1.14)                                            0.421/0.0                       0.96 (0.74--1.25)                                            0.834/0.0
  Caucasian                                                                                                  5 (912/885)                     1.31 (0.95--1.82)                                                                      0.992/0.0                                                                              1.06 (0.64--1.73)                                                                               0.513/0.0                                                                           **1.46 (1.07--1.99)**                                                                                                                             0.108/47.3                      **1.36 (1.03--1.77)**                                        0.678/0.0                       1.92 (0.71--5.17)[\*](#t007fn001){ref-type="table-fn"}       0.029/62.9
  Indian                                                                                                     2 (649/896)                     1.26 (0.86--1.86)                                                                      0.371/0.0                                                                              0.76 (0.47--1.21)                                                                               0.526/0.0                                                                           0.90 (0.68--1.20)                                                                                                                                 0.187/42.5                      0.95 (0.73--1.23)                                            0.239/28.0                      0.56 (0.03--11.41)[\*](#t007fn001){ref-type="table-fn"}      0.038/76.9
  Source of controls                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  NPB                                                                                                        7 (2,099/2,161)                 1.11 (0.84--1.45)                                                                      0.564/0.0                                                                              0.95 (0.68--1.33)                                                                               0.763/0.0                                                                           0.96 (0.75--1.23)                                                                                                                                 0.229/27.4                      1.03 (0.88--1.20)                                            0.524/0.0                       1.52 (0.69--3.37)[\*](#t007fn001){ref-type="table-fn"}       0.016/64.2
  PB                                                                                                         6 (3,296/3,383)                 1.03 (0.87--1.22)                                                                      0.511/0.0                                                                              0.96 (0.77--1.20)                                                                               0.316/15.4                                                                          1.12 (0.85--1.47)[\*](#t007fn001){ref-type="table-fn"}                                                                                            0.040/57.2                      1.02 (0.89--1.17)                                            0.155/37.7                      1.42 (0.96--2.12)[\*](#t007fn001){ref-type="table-fn"}       0.094/46.9
  Type of controls                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Healthy women                                                                                              6 (1,223/1,674)                 1.11 (0.85--1.46)                                                                      0.560/0.0                                                                              0.96 (0.68--1.35)                                                                               0.629/0.0                                                                           1.12 (0.69--1.84)[\*](#t007fn001){ref-type="table-fn"}                                                                                            0.008/68.3                      1.07 (0.87--1.31)                                            0.104/45.2                      1.27 (0.54--2.99)[\*](#t007fn001){ref-type="table-fn"}       0.018/63.2
  Cancer-free women                                                                                          4 (2,610/2,692)                 1.03 (0.86--1.24)                                                                      0.477/0.0                                                                              0.91 (0.73--1.14)                                                                               0.757/0.0                                                                           1.02 (0.84--1.23)                                                                                                                                 0.962/0.0                       1.00 (0.86--1.17)                                            0.911/0.0                       1.45 (0.91--2.30)[\*](#t007fn001){ref-type="table-fn"}       0.059/59.7
  Sample size                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  ≥ 200                                                                                                      11 (5,245/5,334)                1.04 (0.90--1.20)                                                                      0.559/0.0                                                                              0.95 (0.79--1.14)                                                                               0.771/0.0                                                                           1.06 (0.85--1.30)[\*](#t007fn001){ref-type="table-fn"}                                                                                            0.041/48.7                      1.02 (0.92--1.14)                                            0.207/23.8                      1.15 (0.94--1.40)                                            0.102/38.4
  \< 200                                                                                                     2 (150/210)                     1.45 (0.63--3.37)                                                                      0.953/0.0                                                                              1.27 (0.54--2.96)                                                                               0.156/50.2                                                                          0.88 (0.41---1.88)                                                                                                                                0.287/11.6                      1.11 (0.58--2.12)                                            0.948/0.0                       **5.58 (1.96--15.89)**                                       0.171/46.6
  Quality score                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  \> 10                                                                                                      8 (4,367/4,311)                 1.00 (0.85--1.18)                                                                      0.413/1.5                                                                              0.95 (0.78--1.17)                                                                               0.441/0.0                                                                           1.07 (0.82--1.39)[\*](#t007fn001){ref-type="table-fn"}                                                                                            0.046/53.2                      1.02 (0.91--1.15)                                            0.219/26.3                      1.20 (0.97--1.48)                                            0.137/38.2
  ≤10                                                                                                        5 (1,028/1,233)                 1.24 (0.92--1.69)                                                                      0.946/0.0                                                                              0.98 (0.67--1.45)                                                                               0.643/0.0                                                                           0.99 (0.77--1.29)                                                                                                                                 0.203/32.8                      1.05 (0.83--1.31)                                            0.458/0.0                       1.74 (0.56--5.43)[\*](#t007fn001){ref-type="table-fn"}       0.010/70.0
  Matching                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  Yes                                                                                                        7 (3,330/3,880)                 0.97 (0.82--1.14)                                                                      0.721/0.0                                                                              0.98 (0.80--1.20)                                                                               0.733/0.0                                                                           0.91 (0.77--1.06)                                                                                                                                 0.689/0.0                       0.94 (0.82--1.07)                                            0.584/0.0                       1.32 (0.89--1.94)[\*](#t007fn001){ref-type="table-fn"}       0.067/49.0
  No                                                                                                         6 (2,065/1,664)                 **1.39 (1.03--1.86)**                                                                  0.995/0.0                                                                              0.90 (0.56--1.46)                                                                               0.309/16.4                                                                          1.39 (0.91--2.12)[\*](#t007fn001){ref-type="table-fn"}                                                                                            0.085/51.1                      **1.18 (1.00--1.39)**                                        0.562/0.0                       1.81 (0.76--4.32)                                            0.031/62.4
  HWE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  Yes                                                                                                        7 (2,914/3,085)                 1.12 (0.94--1.34)                                                                      0.642/0.0                                                                              0.94 (0.72--1.21)                                                                               0.445/0.0                                                                           1.13 (0.86--1.49)[\*](#t007fn001){ref-type="table-fn"}                                                                                            0.012/63.1                      1.09 (0.89--1.34)[\*](#t007fn001){ref-type="table-fn"}       0.083/46.3                      **1.40 (1.03--1.90)**                                        0.156/35.7
  No                                                                                                         2 (193/236)                     1.20 (0.60--2.41)                                                                      0.795/0.0                                                                              0.78 (0.32--1.91)                                                                               0.747/0.0                                                                           1.14 (0.60--2.18)                                                                                                                                 0.727/0.0                       1.07 (0.61--1.88)                                            0.989/0.0                       2.38 (0.93--6.05)                                            0.825/0.0
  Only studies with high quality, matching, HWE, and genotyping examination done bindly or quality control                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  Yes                                                                                                        3 (1,631/1,642)                 1.16 (0.85--1.58)                                                                      0.222/33.6                                                                             1.05 (0.74--1.48)                                                                               0.201/37.6                                                                          0.95 (0.76--1.17)                                                                                                                                 0.355/3.5                       0.98 (0.81--1.19)                                            0.218/34.3                      **1.84 (1.22--2.77)**                                        0.644/0.0
  **Variable**                                                                                               **Sample size**                 **M1 null/T1 present/P1 Val** ^**1**^ **vs. *M1* present/*T1* present/*P1* IIe/IIe**   **M1 present/T1 null/P1 Val** ^**1**^ **vs. *M1* present/*T1* present/*P1* IIe/IIe**   **all two high-risk genotype *vs*. *M1* present/*T1* present/*P1* IIe/IIe**                     **M1 null/T1 null/P1 Val** ^**1**^ **vs. *M1* present/*T1* present/*P1* IIe/IIe**   **M1 null/T1 null/P1 Val** ^**1**^ **vs. (all one high-risk genotypes + all two high-risk genotypes + *M1* present/*T1* present/*P1* IIe/IIe)**                                                                                                                                                                                             
  **OR (95% CI)**                                                                                            ***P***~**h**~**/*I***^**2**^   **OR (95% CI)**                                                                        ***P***~**h**~**/*I***^**2**^                                                          **OR (95% CI)**                                                                                 ***P***~**h**~**/*I***^**2**^                                                       **OR (95% CI)**                                                                                                                                   ***P***~**h**~**/*I***^**2**^   **OR (95% CI)**                                              ***P***~**h**~**/*I***^**2**^                                                                
  Overall                                                                                                    13 (5,395/5,544)                **1.54 (1.08--2.18)**[\*](#t007fn001){ref-type="table-fn"}                             \<0.001/81.1                                                                           1.06 (0.88--1.28)                                                                               0.167/29.3                                                                          **1.41 (1.08--1.83)**[\*](#t007fn001){ref-type="table-fn"}                                                                                        \<0.001/77.7                    **1.79 (1.19--2.67)**[\*](#t007fn001){ref-type="table-fn"}   \<0.001/72.1                    **1.51 (1.10--2.06)**[\*](#t007fn001){ref-type="table-fn"}   0.001/63.3
  Ethnicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Asian                                                                                                      2 (1,321/1,610)                 1.18 (0.87--1.61)                                                                      0.219/33.9                                                                             1.14 (0.82--1.59)                                                                               0.445/0.0                                                                           1.06 (0.84--1.34)                                                                                                                                 0.582/0.0                       1.37 (0.61--3.06)                                            0.042/75.9                      1.52 (0.57---4.10)[\*](#t007fn001){ref-type="table-fn"}      0.002/89.4
  Caucasian                                                                                                  5 (912/885)                     1.98 (0.92--4.27)[\*](#t007fn001){ref-type="table-fn"}                                 \<0.001/81.3                                                                           1.62 (0.95--2.77)                                                                               0.584/0.0                                                                           **2.07 (1.06--4.04)**[\*](#t007fn001){ref-type="table-fn"}                                                                                        0.001/78.4                      **2.64 (1.23--5.66)**[\*](#t007fn001){ref-type="table-fn"}   0.035/61.4                      **1.63 (1.13--2.36)**                                        0.133/43.3
  Indian                                                                                                     2 (649/896)                     1.87 (0.78--4.48)[\*](#t007fn001){ref-type="table-fn"}                                 0.010/85.1                                                                             1.32 (0.85--2.05)                                                                               0.242/26.8                                                                          1.56 (0.66--3.72)[\*](#t007fn001){ref-type="table-fn"}                                                                                            0.003/88.4                      **3.10 (1.77--5.42)**                                        0.173/46.1                      **2.58 (1.51--4.40)**                                        0.543/0.0
  Source of controls                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  NPB                                                                                                        7 (2,099/2,161)                 1.17 (0.90--1.51)                                                                      0.624/0.0                                                                              1.21 (0.84--1.74)                                                                               0.538/0.0                                                                           1.12 (0.92--1.35)                                                                                                                                 0.338/11.9                      **1.83 (1.30--2.58)**                                        0.432/0.0                       **1.75 (1.29--2.36)**                                        0.206/29.2
  PB                                                                                                         6 (3,296/3,383)                 **1.94 (1.08--3.48)**[\*](#t007fn001){ref-type="table-fn"}                             \<0.001/90.7                                                                           1.05 (0.73--1.51)[\*](#t007fn001){ref-type="table-fn"}                                          0.051/57.5                                                                          **1.71 (1.06--2.75)**[\*](#t007fn001){ref-type="table-fn"}                                                                                        \<0.001/89.1                    1.72 (0.89--3.33)8                                           \<0.001/84.8                    1.28 (0.84--1.97)[\*](#t007fn001){ref-type="table-fn"}       0.004/71.0
  Type of controls                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Healthy women                                                                                              6 (1,223/1,674)                 1.73 (0.93--3.20)[\*](#t007fn001){ref-type="table-fn"}                                 \<0.001/79.5                                                                           1.15 (0.79--1.66)                                                                               0.613/0.0                                                                           1.69 (0.98--2.92)[\*](#t007fn001){ref-type="table-fn"}                                                                                            \<0.001/79.9                    **2.30 (1.62--3.26)**                                        0.125/42.0                      **1.99 (1.46--2.70)**                                        0.230/27.3
  Cancer-free women                                                                                          4 (2,610/2,692)                 1.37 (0.82--2.28)[\*](#t007fn001){ref-type="table-fn"}                                 \<0.001/83.9                                                                           1.17 (0.69--1.96)[\*](#t007fn001){ref-type="table-fn"}                                          0.019/69.7                                                                          1.31 (0.87--1.96)[\*](#t007fn001){ref-type="table-fn"}                                                                                            0.001/80.8                      1.38 (0.74--2.56)[\*](#t007fn001){ref-type="table-fn"}       0.004/77.9                      1.22 (0.77--1.92)[\*](#t007fn001){ref-type="table-fn"}       0.027/67.4
  Sample size                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  ≥ 200                                                                                                      11 (5,245/5,334)                **1.49 (1.02--2.19)**[\*](#t007fn001){ref-type="table-fn"}                             \<0.001/84.2                                                                           1.05 (0.87--1.27)                                                                               0.121/37.2                                                                          **1.34 (1.02--1.76)**[\*](#t007fn001){ref-type="table-fn"}                                                                                        \<0.001/79.6                    **1.60 (1.06--2.41)**[\*](#t007fn001){ref-type="table-fn"}   \<0.001/72.5                    **1.37 (1.00--1.88)**[\*](#t007fn001){ref-type="table-fn"}   0.003/63.0
  \< 200                                                                                                     2 (150/210)                     1.97 (0.93--4.15)                                                                      0.719/0.0                                                                              1.35 (0.49--3.74)                                                                               0.281/13.8                                                                          **2.27 (1.16--4.45)**                                                                                                                             0.272/17.0                      **4.37 (1.75--10.92)**                                       0.752/0.0                       **3.14 (1.47--6.72)**                                        0.968/0.0
  Quality score                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  \> 10                                                                                                      8 (4,367/4,311)                 **1.72 (1.01--2.93)**[\*](#t007fn001){ref-type="table-fn"}                             \<0.001/89.3                                                                           1.02 (0.74--1.40)[\*](#t007fn001){ref-type="table-fn"}                                          0.089/47.6                                                                          **1.45 (1.01--2.09)**[\*](#t007fn001){ref-type="table-fn"}                                                                                        \<0.001/85.5                    **1.72 (1.00--2.94)**[\*](#t007fn001){ref-type="table-fn"}   \<0.001/80.3                    1.43 (0.95--2.14)[\*](#t007fn001){ref-type="table-fn"}       0.001/72.3
  ≤10                                                                                                        5 (1,028/1,233)                 1.24 (0.94--1.63)                                                                      0.704/0.0                                                                              1.33 (0.88--2.02)                                                                               0.524/0.0                                                                           1.24 (0.96--1.59)                                                                                                                                 0.258/24.6                      **1.79 (1.19--2.70)**                                        0.248/26.0                      **1.56 (1.08--2.24)**                                        0.197/33.6
  Matching                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  Yes                                                                                                        7 (3,330/3,880)                 1.10 (0.82--1.47)[\*](#t007fn001){ref-type="table-fn"}                                 0.021/59.8                                                                             0.95 (0.77--1.17)                                                                               0.220/27.3                                                                          1.03 (0.89--1.19)                                                                                                                                 0.107/42.6                      1.18 (0.80--1.75)[\*](#t007fn001){ref-type="table-fn"}       0.025/58.3                      1.19 (0.83--1.72)[\*](#t007fn001){ref-type="table-fn"}       0.012/63.3
  No                                                                                                         6 (2,065/1,664)                 **2.50 (1.29--4.84)**[\*](#t007fn001){ref-type="table-fn"}                             \<0.001/81.0                                                                           **1.57 (1.04--2.37)**                                                                           0.733/0.0                                                                           **2.00 (1.18--3.38)**[\*](#t007fn001){ref-type="table-fn"}                                                                                        \<0.001/83.1                    **2.99 (1.66--5.41)**[\*](#t007fn001){ref-type="table-fn"}   0.049/55.1                      **2.08 (1.35--3.21)**                                        0.176/34.7
  HWE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  Yes                                                                                                        7 (2,914/3,085)                 **1.78 (1.06--3.01)**[\*](#t007fn001){ref-type="table-fn"}                             \<0.001/89.0                                                                           1.06 (0.74--1.51)[\*](#t007fn001){ref-type="table-fn"}                                          0.079/49.4                                                                          **1.61 (1.03--2.50)**[\*](#t007fn001){ref-type="table-fn"}                                                                                        \<0.001/87.0                    **1.87 (1.00--3.50)**                                        \<0.001/80.3                    1.42 (0.93--2.18)[\*](#t007fn001){ref-type="table-fn"}       0.009/64.7
  No                                                                                                         2 (193/236)                     1.13 (0.61--2.10)                                                                      0.395/0.0                                                                              1.48 (0.55--4.03)                                                                               0.226/31.8                                                                          1.30 (0.73--2.31)                                                                                                                                 0.694/0.0                       1.79 (0.75--4.29)[\*](#t007fn001){ref-type="table-fn"}       0.131/56.3                      1.64 (0.46--5.81)[\*](#t007fn001){ref-type="table-fn"}       0.101/62.8
  Only studies with high quality, matching, HWE, and genotyping examination done bindly or quality control                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  Yes                                                                                                        3 (1,631/1,642)                 1.24 (0.65--2.35)[\*](#t007fn001){ref-type="table-fn"}                                 0.002/83.5                                                                             0.76 (0.56--1.04)                                                                               0.271/23.4                                                                          1.20 (0.71--2.04)[\*](#t007fn001){ref-type="table-fn"}                                                                                            0.007/79.6                      1.08 (0.48--2.45)[\*](#t007fn001){ref-type="table-fn"}       0.017/75.5                      0.92 (0.67--1.26)                                            0.161/45.3
  ---------------------------------------------------------------------------------------------------------- ------------------------------- -------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------- ------------------------------------------------------------ ------------------------------- ------------------------------------------------------------ ------------

\* A random-effect model was used when *P* \< 0.10 and/or I^2^ \> 50%; otherwise, a fixed-effects model was used, PB: population-based studies, HWE: Hardy-Weinberg equilibrium; NPB: no population-based studies; Val ^1^:IIe/Val + Val/Val

Heterogeneity and sensitivity analyses {#sec016}
--------------------------------------

Heterogeneity was observed in the current meta-analysis, as shown in Tables [1](#pone.0216147.t001){ref-type="table"}--[7](#pone.0216147.t007){ref-type="table"}. Then, we evaluated heterogeneity source by applying a meta-regression analysis method. The results suggested that source of controls (*P* = 0.027 for *+ − vs*. *+ +*), type of controls (*P* = 0.005 for *− −* vs. *+ +*), and quality score of articles (*− +* vs. *+ +*: *P* = 0.045 for *− −* vs. *+ +*) were source of heterogeneity between the combined effects of *GSTM1* present/null and GSTT1 present/null polymorphisms with BC risk. For the combined effects of *GSTM1* present/null and *GSTP1* IIe105Val polymorphisms, matching (*GSTM1* present/*GSTP1* Val\* vs. *GSTM1* present/*GSTP1* IIe/IIe: *P* = 0.041; all one risk genotypes vs. *GSTM1* present/*GSTP1* IIe/IIe: *P* = 0.018) was source of heterogeneity.

Sensitivity analysis was estimated by applying two methods in this meta-analysis. First, results did not change when removing a single study each time to appraise the robustness in the current meta-analysis. However, when we restrained only high-quality studies, HWE, matching, and genotyping examination performed blindly or with quality control, significantly increased BC risk was found in the overall analysis for the combined effects of *GSTM1*, *GSTT1*, and *GSTP1* IIe105Val polymorphisms (*GSTM1* null/*GSTT1* null/*GSTP1* null vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe: OR = 1.84, 95% CI = 1.22--2.77), *GSTM1* null genotype (OR = 1.06, 95% CI = 1.02--1.11), all races (*− −* vs. *+ +*: OR = 1.27, 95% CI = 1.02--1.59), Caucasians (*− −* vs. *+ +*: OR = 1.58, 95% CI = 1.10--2.29, *− −* vs. (*+ +*) *+* (*− +*) *+* (*+ −*): OR = 1.58, 95% CI = 1.11--2.24), and postmenopausal women (*− − vs*. *+ +*: OR = 1.50, 95% CI = 1.13--2.00, *− − vs*. (*+ +*) *+* (*− +*) *+* (*+ −*): OR = 1.29, 95% CI = 1.03--1.61), and the combined effects of *GSTM1* and *GSTT1* polymorphisms, and, as shown in Tables [7](#pone.0216147.t007){ref-type="table"}--[9](#pone.0216147.t009){ref-type="table"}, respectively; no significant association was observed for the combined of *GSTT1* and *GSTP1* IIe105Val polymorphisms, *GSTT1*,*GSTP1*, and the combined effects of *GSTM1* and *GSTP1* IIe105Val polymorphisms, and, as shown in Tables [6](#pone.0216147.t006){ref-type="table"}, [10](#pone.0216147.t010){ref-type="table"}, [11](#pone.0216147.t011){ref-type="table"} and [12](#pone.0216147.t012){ref-type="table"}, respectively.

10.1371/journal.pone.0216147.t008

###### Pooled estimates of association of *GSTM1* polymorphism and breast cancer risk, only studies with high quality, matching, and genotyping examination done bindly or quality control.

![](pone.0216147.t008){#pone.0216147.t008g}

  Variable            n    Cases/Controls   Test of association     Test of heterogeneity   
  ------------------- ---- ---------------- ----------------------- ----------------------- ------
  Overall             21   14,524/17,745    **1.06 (1.02--1.11)**   0.578                   0.0
  Ethnicity                                                                                 
  African             2    733/701          0.93 (0.74--1.18)       0.658                   0.0
  Asian               5    2,483/3,539      1.04 (0.94--1.15)       0.603                   0.0
  Caucasian           7    7,065/9,184      1.05 (0.99--1.12)       0.695                   0.0
  Menopausal status                                                                         
  Postmenopausal      12   6,524/9,463      0.95 (0.89--1.01)       0.272                   17.5
  Premenopausal       9    1,419/1,910      1.02 (0.88--1.17)       0.535                   0.0
  Smoking habits                                                                            
  Current smoker      2    81/80            0.61 (0.33--1.15)       0.849                   0.0
  Past smoker         2    240/229          0.95 (0.66--1.36)       0.397                   0.0
  Never               2    231/249          1.27 (0.88--1.82)       0.936                   0.0

10.1371/journal.pone.0216147.t009

###### Pooled estimates of association of the combined effects of *GSTM1* present/null and *GSTT1* present/null and breast cancer risk, only studies with high quality, matching, and genotyping examination done bindly or quality control.

![](pone.0216147.t009){#pone.0216147.t009g}

  Variable            N (Case/Control)   \+ − vs. + +                                             − + vs. + +                     − − vs. + +                                                                                                                           
  ------------------- ------------------ -------------------------------------------------------- ------------------------------- -------------------------------------------------------- --------------- ------------------------------------------------------------ ------------
  Overall             9 (5,175/5,055)    0.98 (0.78--1.23)[\*](#t009fn001){ref-type="table-fn"}   0.034/56.1                      1.03 (0.94--1.14)                                        0.269/21.1      **1.27 (1.02--1.59)**[\*](#t009fn001){ref-type="table-fn"}   0.038/53.0
  Ethnicity                                                                                                                                                                                                                                                             
  Asian               3 (1,512/1,948)    1.07 (0.84--1.37)                                        --                              1.05 (0.83--1.32)                                        --              1.31 (0.66--2.61)[\*](#t009fn001){ref-type="table-fn"}       0.023/80.7
  Caucasian           1 (1,235/659)      0.73 (0.51--1.25)                                        --                              1.06 (0.86--1.31)                                        --              **1.58 (1.10--2.29)**                                        --
  Menopausal status                                                                                                                                                                                                                                                     
  Postmenopausal      5 (1,487/1,749)    0.88 (0.55--1.41)[\*](#t009fn001){ref-type="table-fn"}   0.077/61.0                      1.01 (0.84--1.21)                                        0.997/0.0       **1.50 (1.13--2.00)**                                        0.343/10.0
  Premenopausal       4 (621/742)        1.02 (0.44--2.35)[\*](#t009fn001){ref-type="table-fn"}   0.056/65.4                      1.01 (0.77--1.32)                                        0.934/0.0       1.07 (0.61--1.86)[\*](#t009fn001){ref-type="table-fn"}       0.110/50.2
  Variable            Sample size        (+ −) + (− +) vs. + +                                    (+ −) + (− +) + (− −) vs. + +   − − vs. (+ +) + (+ −) + (− +)                                                                                                         
  OR (95% CI)         *P*~h~/*I*^2^      OR (95% CI)                                              *P*~h~/*I*^2^                   OR (95% CI)                                              *P*~h~/*I*^2^                                                                
  Overall             9 (5,175/5,055)    1.02 (0.94--1.12)                                        0.122/38.6                      1.08 (0.96--1.23)[\*](#t009fn001){ref-type="table-fn"}   0.069/46.6      1.16 (0.98--1.38)[\*](#t009fn001){ref-type="table-fn"}       0.067/45.2
  Ethnicity                                                                                                                                                                                                                                                             
  Asian               3 (1,512/1,948)    1.12 (0.93--1.36)                                        0.184/43.3                      1.23 (0.79--1.90)[\*](#t009fn001){ref-type="table-fn"}   0.073/68.8      0.98 (0.84--1.14)                                            0.165/44.5
  Caucasian           1 (1,235/659)      1.00 (0.82--1.22)                                        --                              1.07 (0.88--1.30)                                        --              **1.58 (1.11--2.24)**                                        --
  Menopausal status                                                                                                                                                                                                                                                     
  Postmenopausal      5 (1,487/1,749)    0.98 (0.83--1.16)                                        0.513/0.0                       1.04 (0.89--1.22)                                        0.464/0.0       **1.29 (1.03--1.61)**                                        0.115/46.1
  Premenopausal       4 (621/742)        1.06 (0.84--1.34)                                        0.485/0.0                       1.05 (0.84--1.32)                                        0.423/0.0       0.99 (0.60--1.65)[\*](#t009fn001){ref-type="table-fn"}       0.088/54.2

\* A random-effect model was used when *P* \< 0.10 and/or I^2^ \> 50%; otherwise, a fixed-effects model was used, + −: *GSTM1* present/*GSTT1* null; − +: *GSTM1* null/*GSTT1* present; − −: *GSTM1* null/*GSTT1* null; + +: *GSTM1* present/*GSTT1* present

10.1371/journal.pone.0216147.t010

###### Pooled estimates of association of *GSTT1* polymorphism and breast cancer risk, only studies with high quality, matching, and genotyping examination done bindly or quality control.

![](pone.0216147.t010){#pone.0216147.t010g}

  Variable            n    Cases/Controls   Test of association                                      Test of heterogeneity   
  ------------------- ---- ---------------- -------------------------------------------------------- ----------------------- ------
  Overall             17   12,980/15,456    1.05 (0.96--1.14)[\*](#t010fn001){ref-type="table-fn"}   0.007                   51.5
  Ethnicity                                                                                                                  
  African             2    742/707          1.01 (0.79--1.30)                                        0.277                   15.2
  Asian               4    1,869/2,666      1.01 (0.83--1.23)[\*](#t010fn001){ref-type="table-fn"}   0.098                   52.3
  Caucasian           5    6,605/8,242      1.12 (0.97--1.30)[\*](#t010fn001){ref-type="table-fn"}   0.060                   55.8
  Menopausal status                                                                                                          
  Postmenopausal      9    5,912/8,518      0.93 (0.85--1.02)[\*](#t010fn001){ref-type="table-fn"}   0.064                   45.8
  Premenopausal       6    946/1,034        0.98 (0.79--1.21)                                        0.522                   0.0
  Smoking habits                                                                                                             
  Current smoker      1    51/58            0.84 (0.36--1.99)                                        --                      --
  Past smoker         1    135/130          0.57 (0.32--1.01)                                        --                      --
  Never               1    131/146          0.69 (0.41--1.18)                                        --                      --

\* A random-effect model was used when *P* \< 0.10 and/or I^2^ \> 50%; otherwise, a fixed-effects model was used,

10.1371/journal.pone.0216147.t011

###### Pooled estimates of association of *GSTP1* polymorphism and breast cancer risk, only studies with controls in Hardy-Weinberg equilibrium, high quality, matching, and genotyping examination done bindly or quality control.

![](pone.0216147.t011){#pone.0216147.t011g}

  Variable    Sample size        Val/Val vs. IIe/IIe   IIe/Val vs. IIe/IIe   Val/Val vs. IIe/IIe + IIe/Val   Val/Val + IIe/Val vs. IIe/IIe   Val vs IIe                                                                           
  ----------- ------------------ --------------------- --------------------- ------------------------------- ------------------------------- ------------------- ----------- ------------------- ------------ ------------------- ------------
  Overall     12 (7,282/6,774)   0.95 (0.84--1.06)     0.521/0.0             0.96 (0.90--1.03)               0.209/23.9                      0.97 (0.87--1.08)   0.650/0.0   0.96 (0.90--1.03)   0.182/26.7   0.97 (0.92--1.02)   0.245/20.2
  Ethnicity                                                                                                                                                                                                                       
  African     2 (720/692)        0.81 (0.59--1.09)     0.776/0.0             0.88 (0.68--1.12)               0.916/0.0                       0.88 (0.68--1.14)   0.656/0.0   0.86 (0.68--1.08)   0.987/0.0    0.90 (0.78--1.05)   0.765/0.0
  Asian       2 (784/1,047)      0.96 (0.57--1.61)     0.702/0.0             1.09 (0.89--1.33)               0.136/55.0                      0.93 (0.55--1.56)   0.839/0.0   1.08 (0.89--1.30)   0.134/55.5   1.05 (0.89--1.23)   0.175/45.7
  Caucasian   5 (3,725/2,959)    0.99 (0.85--1.17)     0.744/0.0             0.95 (0.85--1.05)               0.197/33.7                      1.02 (0.88--1.19)   0.925/0.0   0.96 (0.87--1.05)   0.190/34.6   0.98 (0.91--1.05)   0.333/12.7

10.1371/journal.pone.0216147.t012

###### Pooled estimates of association of the combined effects of *GSTM1* present/null and *GSTP1* IIe105Val and breast cancer risk, only studies with high quality, matching, HWE, and genotyping examination done bindly or quality control.

![](pone.0216147.t012){#pone.0216147.t012g}

  ----------------- ------------------------------- ----------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------- ------------------------------------------------------------ ------------
  **Variable**      **Sample size**                 ***GSTM1* null/ *GSTP1* IIe/IIe vs. *GSTM1* present/ *GSTP1* IIe/IIe**                                      ***GSTM1* present/GSTP1 Val** ^**1**^ **vs. *GSTM1* present/ *GSTP1* IIe/IIe**   **(*GSTM1* null/ *GSTP1* IIe/IIe + *GSTM1* present/*GSTP1* Val** ^**1**^**) vs. *GSTM1* present/*GSTP1* IIe/IIe**                                                                                                                                                                                       
  **OR (95% CI)**   ***P***~**h**~**/*I***^**2**^   **OR (95% CI)**                                                                                             ***P***~**h**~**/*I***^**2**^                                                    **OR (95% CI)**                                                                                                                                                                                            ***P***~**h**~**/*I***^**2**^                                                                
  Overall           4 (2,488/2,524)                 1.12 (0.96--1.32)                                                                                           0.677/0.0                                                                        0.95 (0.81--1.12)                                                                                                                                                                                          0.417/0.0                       1.03 (0.90--1.19)                                            0.370/4.6
  Ethnicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Asian             1 (613/876)                     1.13 (0.87--1.47)                                                                                           --                                                                               1.12 (0.83--1.52)                                                                                                                                                                                          --                              1.13 (0.89--1.43)                                            --
  **Variable**      **Sample size**                 ***GSTM1* null/ GSTP1 Val[\*](#t012fn002){ref-type="table-fn"}** **vs. *GSTM1* present/ *GSTP1* IIe/IIe**   **all risk genotypes vs. *GSTM1* present/ *GSTP1* IIe/IIe**                      ***GSTM1* null/ GSTP1 Val[\*](#t012fn002){ref-type="table-fn"}vs. (*GSTM1* null/ *GSTP1* IIe/IIe + *GSTM1* present/*GSTP1* Val[\*](#t012fn002){ref-type="table-fn"}+ *GSTM1* present/ *GSTP1* IIe/IIe)**                                                                                                
  **OR (95% CI)**   ***P***~**h**~**/*I***^**2**^   **OR (95% CI)**                                                                                             ***P***~**h**~**/*I***^**2**^                                                    **OR (95% CI)**                                                                                                                                                                                            ***P***~**h**~**/*I***^**2**^                                                                
  Overall           4 (2,488/2,524)                 1.17 (0.77--1.77)**[\*](#t012fn002){ref-type="table-fn"}**                                                  0.001/80.9                                                                       1.07 (0.84--1.36)**[\*](#t012fn002){ref-type="table-fn"}**                                                                                                                                                 0.041/63.7                      1.14 (0.83--1.57)**[\*](#t012fn002){ref-type="table-fn"}**   0.002/79.1
  Ethnicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Asian             1 (613/876)                     1.33 (0.99--1.80)                                                                                           --                                                                               1.18 (0.95--1.48)                                                                                                                                                                                          --                              1.24 (0.95--1.61)                                            --
  ----------------- ------------------------------- ----------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------- ------------------------------------------------------------ ------------

Val ^1^:IIe/Val + Val/Val,

\* A random-effect model was used when *P* \< 0.10 and/or I^2^ \> 50%; otherwise, a fixed-effects model was used,

Evaluation of publication bias {#sec017}
------------------------------

There was no evidence of publication bias for *GSTM1* (*P* = 0.223, [S1 Fig](#pone.0216147.s013){ref-type="supplementary-material"}), *GSTT1* (*P* = 0.079, [S2 Fig](#pone.0216147.s014){ref-type="supplementary-material"}), and *GSTP1* IIe105Val (Val/Val vs. IIe/IIe: *P* = 0.884, IIe/Val vs. IIe/IIe: *P* = 0.153; Val/Val vs. IIe/IIe +IIe/Val: *P* = 0.596; Val vs. IIe: *P* = 0.505; Val/Val + IIe/Val vs. IIe/IIe: *P* = 0.478, [S3](#pone.0216147.s015){ref-type="supplementary-material"}--[S7](#pone.0216147.s019){ref-type="supplementary-material"} Figs) on BC risk. However, there was significant evidence of publication bias for the combined effects of both *GSTM1* and *GSTT1* polymorphisms (*− −* vs. *+ +*: *P* \< 0.001, (*+ −*) + (*− +*) vs. (*+ +*): *P* = 0.005, (*− +*) *+* (*+ −*) + (*− −*) vs. *+ +*: *P =* 0.002, *− −* vs. (*− +*) *+* (*+ −*) + (*+ +*): *P =* 0.001), the combined effects of *GSTM1* and *GSTP1* IIe105Val polymorphisms (*GSTM1* null/*GSTP1* Val\* vs. *GSTM1* present/*GSTP1* IIe/IIe: *P =* 0.038, all risk genotypes vs. *GSTM1* present/*GSTP1* IIe/IIe: *P =* 0.028), the combined effects of *GSTT1* and *GSTP1* IIe105Val polymorphisms (*GSTT1* null/*GSTP1* val\* vs. G*STT1* present/*GSTP1* IIe/IIe: *P* = 0.014, all risk genotypes vs. *GSTT1* present/*GSTP1* IIe/IIe: *P* = 0.045, *GSTT1* null/*GSTP1* val\* vs. *GSTT1* null/*GSTP1* IIe/IIe *+ GSTT1* present/*GSTP1 Val\* + GSTT1* present/*GSTP1* IIe/IIe: *P =* 0.017), and the combined effects of *GSTM1*, *GSTT1*, and *GSTP1* IIe105Val polymorphisms (all two high-risk genotype vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe: *P* = 0.043, *GSTM1* null/*GSTT1* null/*GSTP1* Val \* vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe: *P* = 0.019, *GSTM1* null/*GSTT1* null/*GSTP1* Val\* vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe + all one high risk genotypes + all two high risk genotypes: *P* = 0.036). [S8](#pone.0216147.s020){ref-type="supplementary-material"}--[S19](#pone.0216147.s031){ref-type="supplementary-material"} Figs list the funnel plots of the nonparametric 'trim and fill' method. No significant association was observed for the combined effects of *GSTM1* and *GSTT1* polymorphisms (*− −* vs. *+ +*: OR = 1.19, 95% CI = 0.92--1.52, (*+ −*) + (*− +*) vs. (*+ +*): OR = 1.09, 95% CI = 0.96--1.23, (*− +*) *+* (*+ −*) + (*− −*) vs. *+ +*: OR = 1.12, 95% CI = 0.97--1.29, *− − vs*. (*− +*) *+* (*+ −*) + (*+ +*): OR = 1.14, 95% CI = 0.95--1.37), the combined effects of *GSTM1* and *GSTP1* IIe105Val (*GSTM1* null/*GSTP1* Val\* vs. *GSTM1* present/*GSTP1* IIe/IIe: OR = 1.16, 95% CI = 0.86--1.56, all risk genotypes vs. *GSTM1* present/*GSTP1* IIe/IIe: OR = 1.05, 95% CI = 0.87--1.27), the combined effects of *GSTT1* and *GSTP1* IIe105Val (*GSTT1* null/*GSTP1* val\* vs. *GSTT1* present/*GSTP1* IIe/IIe: OR = 1.03, 95% CI = 0.77--1.36, all risk genotypes vs. *GSTT1* present/*GSTP1* IIe/IIe: OR = 1.06, 95% CI = 0.86--1.31, *GSTT1* null/*GSTP1* Val\* vs. *GSTT1* null/*GSTP1* IIe/IIe + *GSTT1* present/*GSTP1* Val\* + *GSTT1* present/*GSTP1* IIe/IIe: OR = 1.02, 95% CI = 0.83--1.26), and the combined effects of *GSTM1*, *GSTT1*, and *GSTP1* IIe105Val polymorphisms (all two high-risk genotype vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe: OR = 1.19, 95% CI = 0.88--1.61, *GSTM1* null/*GSTT1* null/*GSTP1* Val \* vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe: OR = 1.11, 95% CI = 0.72--1.72, *GSTM1* null/*GSTT1* null/*GSTP1* Val\* vs. *GSTM1* present/*GSTT1* present/*GSTP1* IIe/IIe + all one high risk genotypes + all two high risk genotypes: OR = 1.04, 95% CI = 0.74--1.47) on BC risk in all populations.

Credibility of the current and previous meta-analyses {#sec018}
-----------------------------------------------------

Statistically significant associations were considered as "positive results" when they met the following criteria \[[@pone.0216147.ref044]\]: (1) *P* value \< 0.05 was observed in at least one of the two genetic model (individual *GSTM1* and *GSTT1* polymorphisms with BC risk (there was no need to meet this condition between *GSTM1* and *GSTT1* polymorphisms and BC risk because they only used null vs. present); (2) FPRP \< 0.2; (3) statistical power \> 0.8; and (4) *I*^2^ \< 50%. Associations were considered to be "less-credible positive results" if they did not meet the above criteria. Tables [13](#pone.0216147.t013){ref-type="table"} and [14](#pone.0216147.t014){ref-type="table"} list the statistically significant association, *I*^2^ value, statistical power and FPRP value for the current and previous meta-analyses, respectively. We identified "less-credible positive results" for the current and previous meta-analyses on the basis of above criteria.

10.1371/journal.pone.0216147.t013

###### False-positive report probability values for the current meta-analysis.

![](pone.0216147.t013){#pone.0216147.t013g}

  Variables                                                                                                                            OR (95% CI)           *I*^2^ (%)   Statistical power   Prior probability of 0.001           
  ------------------------------------------------------------------------------------------------------------------------------------ --------------------- ------------ ------------------- ---------------------------- ------- -----------
  *GSTM1* (null vs. present)                                                                                                                                                                                                       
  Overall                                                                                                                              1.12 (1.06--1.19)     **59.9**     0.987               1.000                        0.201   **0.199**
  Asian                                                                                                                                1.20 (1.05--1.38)     66.5         0.500               0.999                        0.955   0.914
  PB                                                                                                                                   1.15 (1.06--1.25)     69.1         0.841               1.000                        0.547   0.504
  Healthy women                                                                                                                        1.21 (1.06--1.39)     67.7         0.453               0.999                        0.940   0.870
  Cancer-free women                                                                                                                    1.07 (1.00--1.13)     46.6         1.000               1.000                        0.938   0.938
  Cancer-free patients                                                                                                                 1.50 (1.05--2.14)     63.7         0.109               0.500                        0.996   0.981
  Matching                                                                                                                             1.07 (1.02--1.13)     28.7         1.000               1.000                        0.938   0.938
  Non-matching                                                                                                                         1.19 (1.05--1.34)     72.0         0.555               1.000                        0.880   0.803
  ≥ 200                                                                                                                                1.09 (1.03--1.16)     62.2         0.999               1.000                        0.869   0.869
  \< 200                                                                                                                               1.41 (1.14--1.74)     38.6         0.066               0.718                        0.954   0.655
  \> 10                                                                                                                                1.07 (1.03--1.11)     0.0          1.000               1.000                        0.232   0.232
  ≤10                                                                                                                                  1.18 (1.05--1.32)     69.4         0.616               1.000                        0.861   0.792
  Postmenopausal                                                                                                                       1.17 (1.05--1.30)     50.1         0.681               1.000                        0.837   0.777
  Premenopausal                                                                                                                        1.18 (1.01--1.38)     48.3         0.583               0.999                        0.985   0.975
  Only studies with high quality, matching, and genotyping examination done bindly or quality control                                                                                                                              
  Yes                                                                                                                                  1.06 (1.02--1.11)     0.0          1.000               1.000                        0.930   0.930
  *GSTT1* (null vs. present)                                                                                                                                                                                                       
  Overall                                                                                                                              1.15 (1.06--1.25)\*   63.4         0.841               1.000                        0.547   0.504
  Caucasian                                                                                                                            1.20 (1.07--1.34)     45.7         0.500               1.000                        0.766   0.546
  HB                                                                                                                                   1.19 (1.03--1.37)     52.3         0.546               0.999                        0.966   0.939
  Healthy women                                                                                                                        1.32 (1.09--1.60)     68.5         0.166               0.904                        0.966   0.838
  Cancer-free patients                                                                                                                 1.59 (1.22--2.07)     34.9         0.018               0.333                        0.969   0.631
  Matching                                                                                                                             1.09 (1.00--1.19)     51.3         0.984               1.000                        0.982   0.982
  Non-matching                                                                                                                         1.24 (1.04--1.46)     71.9         0.401               0.927                        0.996   0.991
  ≥ 200                                                                                                                                1.13 (1.04--1.23)     66.9         0.918               1.000                        0.982   0.982
  \< 200                                                                                                                               1.34 (1.08--1.65)     30.0         0.149               0.856                        0.975   0.872
  ≤10                                                                                                                                  1.25 (1.08--1.44)     64.6         0.286               0.994                        0.875   0.667
  Premenopausal                                                                                                                        1.31 (1.02--1.67)     43.6         0.239               0.863                        0.992   0.971
  *GSTP1* (Val/Val vs. IIe/IIe)                                                                                                                                                                                                    
  Asian                                                                                                                                1.30 (1.08--1.57)     0.0          0.203               0.931                        0.969   0.873
  Indian                                                                                                                               1.58 (1.01--2.47)     57.2         0.114               0.410                        0.997   0.991
  *GSTP1* (IIe/Val vs. IIe/IIe)                                                                                                                                                                                                    
  HB                                                                                                                                   1.14 (1.01--1.30)     34.0         0.778               1.000                        0.985   0.981
  Matching                                                                                                                                                                                                                         
  Non-matching                                                                                                                         1.18 (1.06--1.31)     56.1         0.624               1.000                        0.754   0.656
  ≤10                                                                                                                                  1.15 (1.04--1.27)     0.0          0.800               1.000                        0.878   0.852
  *GSTP1* (Val/Val vs. IIe/IIe + IIe/Val)                                                                                                                                                                                          
  Asian                                                                                                                                1.25 (1.04--1.51)     0.0          0.336               0.971                        0.984   0.955
  Indian                                                                                                                               1.45 (1.14--1.85)     36.4         0.064               0.607                        0.978   0.821
  *GSTP1* (Val/Val + IIe/Val vs. IIe/IIe)                                                                                                                                                                                          
  Asian                                                                                                                                1.12 (1.04--1.20)     33.8         0.975               1.000                        0.568   0.562
  HB                                                                                                                                   1.11 (1.01--1.21)     29.3         0.962               1.000                        0.948   0.947
  Non-matching                                                                                                                         1.16 (1.04--1.30)     65.1         0.720               1.000                        0.937   0.914
  ≤10                                                                                                                                  1.12 (1.03--1.23)     25.2         0.926               1.000                        0.950   0.947
  *GSTP1* (Val vs. IIe)                                                                                                                                                                                                            
  Asian                                                                                                                                1.12 (1.05--1.19)     **42.6**     0.987               1.000                        0.201   **0.199**
  Non-matching                                                                                                                         1.15 (1.04--1.27)     73.8         0.800               1.000                        0.878   0.852
  ≤10                                                                                                                                  1.12 (1.01--1.24)     47.0         0.968               1.000                        0.970   0.967
  The combined effects of *GSTM1* and *GSTT1* polymorphisms                                                                                                                                                                        
  \+ − vs. + +                                                                                                                                                                                                                     
  Patients                                                                                                                             1.74 (1.03--2.95)     --           0.084               0.291                        0.998   0.993
  − + vs. + +                                                                                                                                                                                                                      
  Overall                                                                                                                              1.18 (1.03--1.35)     58.6         0.597               1.000                        0.964   0.941
  Indian                                                                                                                               1.70 (1.09--2.64)     52.9         0.060               0.289                        0.997   0.984
  PB                                                                                                                                   1.26 (1.01--1.56)     77.9         0.327               0.945                        0.990   0.973
  ≥ 200                                                                                                                                1.18 (1.03--1.36)     62.7         0.592               1.000                        0.974   0.957
  ≤10                                                                                                                                  1.36 (1.07--1.72)     62.3         0.148               0.793                        0.986   0.928
  Non-matching                                                                                                                         1.47 (1.07--2.01)     74.8         0.102               0.550                        0.994   0.966
  − − vs. + +                                                                                                                                                                                                                      
  Overall                                                                                                                              1.65 (1.31--2.07)     73.8         0.003               0.205                        0.835   0.068
  Asian                                                                                                                                2.06 (1.10--3.84)     84.4         0.044               0.159                        0.998   0.993
  Caucasian                                                                                                                            1.93 (1.31--2.83)     67.2         0.007               0.098                        0.990   0.885
  HB                                                                                                                                   1.58 (1.21--2.06)     0.0          0.021               0.351                        0.972   0.674
  PB                                                                                                                                   1.40 (1.08--1.82)     65.5         0.125               0.697                        0.990   0.945
  Healthy women                                                                                                                        2.05 (1.28--3.26)     70.2         0.012               0.093                        0.995   0.963
  Cancer-free women                                                                                                                    1.68 (1.23--2.29)     74.9         0.017               0.237                        0.984   0.813
  ≥ 200                                                                                                                                1.56 (1.24--1.96)     74.7         0.012               0.368                        0.917   0.267
  \< 200                                                                                                                               3.82 (1.76--8.29)     0.0          0.002               0.009                        0.998   0.987
  \> 10                                                                                                                                1.23 (1.01--1.50)     58.6         0.404               0.975                        0.990   0.977
  ≤10                                                                                                                                  2.45 (1.58--3.81)     72.9         0.001               0.015                        0.989   0.825
  Matching                                                                                                                             1.33 (1.10--1.60)     40.3         0.138               0.899                        0.948   0.735
  Non-matching                                                                                                                         2.30 (1.38--3.82)     85.0         0.006               0.049                        0.995   0.963
  Postmenopausal                                                                                                                       1.49 (1.14--1.94)     0.0          0.054               0.520                        0.983   0.855
  (+ −) + (− +) vs. + +                                                                                                                                                                                                            
  Overall                                                                                                                              1.17 (1.05--1.30)     55.9         0.681               1.000                        0.837   0.777
  Indian                                                                                                                               1.48 (1.19--1.84)     37.1         0.030               0.548                        0.934   0.432
  Healthy women                                                                                                                        1.31 (1.04--1.65)     57.2         0.228               0.875                        0.990   0.961
  ≥ 200                                                                                                                                1.15 (1.04--1.28)     55.7         0.782               1.000                        0.931   0.913
  ≤10                                                                                                                                  1.36 (1.09--1.69)     62.4         0.129               0.812                        0.977   0.872
  Non-matching                                                                                                                         1.35 (1.09--1.67)     71.2         0.139               0.834                        0.976   0.872
  (+ −) + (− +) + (− −) vs. + +                                                                                                                                                                                                    
  Overall                                                                                                                              1.27 (1.12--1.43)     68.0         0.175               0.997                        0.311   0.073
  Caucasian                                                                                                                            1.36 (1.10--1.68)     71.1         0.123               0.818                        0.972   0.841
  Indian                                                                                                                               1.54 (1.02--2.32)     60.0         0.116               0.450                        0.997   0.989
  HB                                                                                                                                   1.22 (1.01--1.47)     0.0          0.431               0.985                        0.988   0.974
  PB                                                                                                                                   1.23 (1.04--1.45)     73.7         0.384               0.991                        0.973   0.932
  Healthy women                                                                                                                        1.43 (1.10--1.85)     67.8         0.091               0.642                        0.986   0.910
  Cancer-free women                                                                                                                    1.23 (1.04--1.46)     70.6         0.389               0.988                        0.979   0.948
  ≥ 200                                                                                                                                1.25 (1.11--1.41)     69.3         0.253               0.998                        0.527   0.220
  ≤10                                                                                                                                  1.53 (1.19--1.96)     72.9         0.027               0.438                        0.966   0.636
  Non-matching                                                                                                                         1.51 (1.20--1.91)     80.0         0.028               0.478                        0.955   0.551
  − − vs. (+ +) + (+ −) + (− +)                                                                                                                                                                                                    
  Overall                                                                                                                              1.41 (1.19--1.68)     65.9         0.036               0.756                        0.773   0.138
  Asian                                                                                                                                1.53 (1.01--2.31)     82.5         0.124               0.462                        0.997   0.989
  Caucasian                                                                                                                            1.61 (1.22--2.12)     46.7         0.018               0.307                        0.974   0.693
  HB                                                                                                                                   1.42 (1.16--1.75)     7.0          0.057               0.696                        0.946   0.590
  PB                                                                                                                                   1.22 (1.01--1.49)     54.0         0.436               0.979                        0.992   0.981
  Healthy women                                                                                                                        1.67 (1.25--2.23)     49.7         0.013               0.l233                       0.976   0.686
  Cancer-free women                                                                                                                    1.46 (1.13--1.88)     72.9         0.064               0.583                        0.981   0.852
  ≥ 200                                                                                                                                1.34 (1.13--1.60)     68.0         0.111               0.894                        0.916   0.576
  \< 200                                                                                                                               2.77 (1.61--4.78)     0.0          0.001               0.014                        0.995   0.948
  ≤10                                                                                                                                  1.82 (1.36--2.43)     57.7         0.002               0.095                        0.954   0.340
  Matching                                                                                                                             1.25 (1.05--1.48)     46.5         0.318               0.983                        0.968   0.907
  Non-matching                                                                                                                         1.81 (1.24--2.62)     78.4         0.015               0.160                        0.991   0.912
  Postmenopausal                                                                                                                       1.25 (1.02--1.53)     23.9         0.346               0.961                        0.989   0.969
  Only studies with high quality, matching, and genotyping examination done bindly or quality control                                                                                                                              
  − − vs. + +                                                                                                                                                                                                                      
  Overall                                                                                                                              1.27 (1.02--1.59)     53.0         0.310               0.927                        0.992   0.976
  Caucasian                                                                                                                            1.58 (1.10--2.29)     --           0.073               0.392                        0.995   0.976
  Postmenopausal                                                                                                                       1.50 (1.13--2.00)     10.0         0.064               0.500                        0.989   0.920
  − − vs. (+ +) + (+ −) + (− +)                                                                                                                                                                                                    
  Caucasian                                                                                                                            1.58 (1.11--2.24)     --           0.061               0.385                        0.994   0.964
  Postmenopausal                                                                                                                       1.29 (1.03--1.61)     46.1         0.261               0.909                        0.989   0.964
  The combined effects of *GSTM1* and *GSTP1* IIe/Val polymorphisms                                                                                                                                                                
  *GSTM1* Null/ *GSTP1* IIe/IIe vs. *GSTM1* Present/ *GSTP1* IIe/IIe                                                                                                                                                               
  Caucasian                                                                                                                            1.37 (1.03--1.83)     0.0          0.185               0.730                        0.994   0.978
  \< 200                                                                                                                               2.07 (1.09--3.94)     0.0          0.048               0.163                        0.998   0.994
  Non-matching                                                                                                                         1.48 (1.14--1.91)     0.0          0.054               0.541                        0.980   0.827
  Yes (HWE)                                                                                                                            1.16 (1.02--1.33)     0.0          0.686               1.000                        0.980   0.971
  (*GSTM1* Null/ *GSTP1* IIe/IIe + *GSTM1* Present/*GSTP1* Val\*) vs. *GSTM1* Present/ *GSTP1* IIe/IIe                                                                                                                             
  Overall                                                                                                                              1.14 (1.00--1.31)     52.8         0.765               1.000                        0.988   0.985
  Caucasian                                                                                                                            1.60 (1.29--1.98)     19.5         0.004               0.276                        0.791   0.053
  Non-matching                                                                                                                         1.46 (1.14--1.87)     55.1         0.060               0.585                        0.978   0.823
  *GSTM1* Null/ GSTP1 Val\* vs. *GSTM1* Present/ *GSTP1* IIe/IIe                                                                                                                                                                   
  Overall                                                                                                                              1.58 (1.21--2.06)     82.2         0.021               0.351                        0.972   0.674
  Asian                                                                                                                                1.23 (1.03--1.46)     0.0          0.389               0.988                        0.979   0.948
  Caucasian                                                                                                                            2.11 (1.21--3.66)     79.6         0.022               0.112                        0.997   0.986
  NPB                                                                                                                                  1.41 (1.17--1.70)     7.0          0.046               0.742                        0.875   0.300
  PB                                                                                                                                   1.74 (1.10--2.76)     91.5         0.057               0.264                        0.997   0.986
  Healthy women                                                                                                                        1.86 (1.32--2.62)     72.7         0.006               0.109                        0.984   0.779
  ≥ 200                                                                                                                                1.52 (1.15--2.01)     83.9         0.049               0.463                        0.986   0.877
  \< 200                                                                                                                               2.36 (1.32--4.22)     0.0          0.011               0.063                        0.997   0.984
  \> 10                                                                                                                                1.61 (1.11--2.35)     88.7         0.064               0.357                        0.995   0.974
  ≤10                                                                                                                                  1.47 (1.18--1.83)     26.5         0.035               0.572                        0.942   0.497
  Non-matching                                                                                                                         2.30 (1.44--3.69)     81.2         0.003               0.038                        0.994   0.935
  Yes (HWE)                                                                                                                            1.74 (1.17--2.60)     88.8         0.035               0.234                        0.995   0.967
  All risk genotypes vs. *GSTM1* Present/ *GSTP1* IIe/IIe                                                                                                                                                                          
  Overall                                                                                                                              1.28 (1.08--1.52)     73.5         0.231               0.965                        0.955   0.835
  Caucasian                                                                                                                            1.77 (1.26--2.48)     58.6         0.012               0.168                        0.987   0.843
  NPB                                                                                                                                  1.24 (1.01--1.54)     55.1         0.383               0.957                        0.993   0.982
  PB                                                                                                                                   1.33 (1.01--1.74)     83.9         0.227               0.810                        0.994   0.979
  Healthy women                                                                                                                        1.44 (1.10--1.89)     72.6         0.094               0.616                        0.989   0.933
  ≥ 200                                                                                                                                1.26 (1.05--1.50)     76.2         0.292               0.975                        0.970   0.906
  \< 200                                                                                                                               1.64 (1.01--2.66)     0.0          0.103               0.359                        0.998   0.992
  \> 10                                                                                                                                1.23 (1.00--1.52)     79.0         0.410               0.967                        0.993   0.983
  ≤10                                                                                                                                  1.39 (1.02--1.89)     60.7         0.174               0.686                        0.995   0.981
  Non-matching                                                                                                                         1.74 (1.26--2.39)     76.6         0.011               0.180                        0.983   0.777
  Yes (HWE)                                                                                                                            1.41 (1.08--1.83)     82.7         0.113               0.679                        0.989   0.935
  *GSTM1* Null/ GSTP1 Val\* vs. (*GSTM1* Null/ *GSTP1* IIe/IIe + *GSTM1* Present/*GSTP1* Val\* + *GSTM1* Present/ *GSTP1* IIe/IIe)                                                                                                 
  Overall                                                                                                                              1.40 (1.12--1.75)     82.4         0.088               0.728                        0.973   0.811
  Asian                                                                                                                                1.21 (1.04--1.41)     0.0          0.458               0.997                        0.970   0.936
  Indian                                                                                                                               2.02 (1.14--3.59)     78.3         0.038               0.155                        0.998   0.991
  NPB                                                                                                                                  1.19 (1.02--1.38)     35.3         0.544               0.999                        0.975   0.955
  PB                                                                                                                                   1.58 (1.08--2.29)     91.3         0.073               0.392                        0.995   0.976
  Cancer-free women                                                                                                                    1.57 (1.15--2.15)     77.9         0.047               0.388                        0.991   0.927
  ≥ 200                                                                                                                                1.35 (1.07--1.70)     84.1         0.158               0.815                        0.985   0.929
  \< 200                                                                                                                               1.99 (1.24--3.20)     0.0          0.018               0.122                        0.996   0.974
  \> 10                                                                                                                                1.51 (1.11--2.06)     88.5         0.074               0.483                        0.992   0.951
  Non-matching                                                                                                                         1.76 (1.13--2.76)     86.6         0.048               0.243                        0.997   0.983
  Yes (HWE)                                                                                                                            1.47 (1.06--2.04)     88.8         0.112               0.548                        0.995   0.975
  The combined effects of *GSTT1* and *GSTP1* IIe/Val polymorphisms                                                                                                                                                                
  GSTT1 Present/GSTP1 Val\* vs. *GSTT1* Present/ *GSTP1* IIe/IIe                                                                                                                                                                   
  PB                                                                                                                                   1.48 (1.02--2.15)     88.5         0.136               0.528                        0.997   0.987
  (*GSTT1* Null/ *GSTP1* IIe/IIe + *GSTT1* Present/*GSTP1* Val\*) vs. *GSTT1* Present/ *GSTP1* IIe/IIe                                                                                                                             
  PB                                                                                                                                   1.40 (1.02--1.93)     86.6         0.173               0.663                        0.996   0.984
  \> 10                                                                                                                                1.28 (1.00--1.62)     81.9         0.296               0.907                        0.993   0.978
  *GSTT1* Null/ GSTP1 Val\* vs. *GSTT1* Present/ *GSTP1* IIe/IIe                                                                                                                                                                   
  Overall                                                                                                                              1.44 (1.10--1.88)     68.4         0.090               0.618                        0.988   0.922
  Caucasian                                                                                                                            2.09 (1.15--3.80)     60.8         0.034               0.138                        0.998   0.991
  NPB                                                                                                                                  1.51 (1.18--1.93)     0.0          0.033               0.479                        0.968   0.675
  Healthy women                                                                                                                        1.85 (1.21--2.82)     56.8         0.022               0.165                        0.995   0.962
  ≥ 200                                                                                                                                1.36 (1.03--1.79)     69.9         0.186               0.758                        0.993   0.974
  \< 200                                                                                                                               2.30 (1.16--4.54)     19.4         0.030               0.109                        0.998   0.993
  ≤10                                                                                                                                  1.39 (1.04--1.87)     0.0          0.166               0.693                        0.994   0.977
  Non-matching                                                                                                                         2.12 (1.37--3.28)     51.6         0.005               0.060                        0.993   0.925
  All risk genotypes vs. *GSTT1* Present/ *GSTP1* IIe/IIe                                                                                                                                                                          
  Overall                                                                                                                              1.23 (1.03--1.48)     76.3         0.397               0.982                        0.986   0.966
  PB                                                                                                                                   1.42 (1.02--1.99)     88.9         0.164               0.625                        0.996   0.985
  \> 10                                                                                                                                1.32 (1.02--1.69)     84.8         0.225               0.845                        0.992   0.970
  Non-matching                                                                                                                         1.54 (1.05--2.28)     83           0.106               0.448                        0.997   0.986
  *GSTT1* Null/ GSTP1 Val\* vs. (*GSTT1* null/ *GSTP1* IIe/IIe + *GSTT1* Present/*GSTP1* Val\* + *GSTT1* Present/ *GSTP1* IIe/IIe)                                                                                                 
  Overall                                                                                                                              1.26 (1.03--1.54)     52.7         0.317               0.956                        0.987   0.962
  Caucasian                                                                                                                            1.50 (1.11--2.02)     8.4          0.071               0.500                        0.991   0.938
  Indian                                                                                                                               1.55 (1.12--2.15)     0.0          0.063               0.422                        0.993   0.953
  NPB                                                                                                                                  1.48 (1.18--1.85)     0.0          0.136               0.528                        0.997   0.987
  Healthy women                                                                                                                        1.52 (1.21--1.92)     0.0          0.024               0.456                        0.949   0.493
  \< 200                                                                                                                               1.87 (1.05--3.31)     17.2         0.064               0.225                        0.998   0.993
  ≤10                                                                                                                                  1.38 (1.06--1.81)     0.0          0.156               0.727                        0.992   0.965
  Non-matching                                                                                                                         1.60 (1.25--2.04)     0.0          0.010               0.301                        0.936   0.331
  The combined effects of *GSTM1* present/null, *GSTT1* present/null and *GSTP1* present/null                                                                                                                                      
  *M1* Null/*T1* Present/*P1* IIe/IIe vs. *M1* Present/*T1* Present/*P1* IIe/IIe                                                                                                                                                   
  Non-matching                                                                                                                         1.39 (1.03--1.86)     0.0          0.161               0.696                        0.994   0.975
  *M1* Present/*T1* Present/*P1* Val ^1^ vs. *M1* Present/*T1* Present/*P1* IIe/IIe                                                                                                                                                
  Caucasian                                                                                                                            1.46 (1.07--1.99)     47.3         0.107               0.568                        0.994   0.967
  All one high-risk genotype vs. vs. *M1* Present/*T1* Present/*P1* IIe/IIe                                                                                                                                                        
  Caucasian                                                                                                                            1.36 (1.03--1.77)     0.0          0.176               0.767                        0.992   0.967
  Non-matching                                                                                                                         1.18 (1.00--1.39)     0.0          0.580               0.998                        0.988   0.979
  M1 Null/T1 Null/P1 IIe/IIe vs. *M1* Present/*T1* Present/*P1* IIe/IIe                                                                                                                                                            
  Overall                                                                                                                              1.44 (1.00--2.06)     52.9         0.159               0.588                        0.997   0.987
  \< 200                                                                                                                               5.58 (1.96--15.89)    46.6         0.002               0.007                        0.998   0.995
  Yes (HWE)                                                                                                                            1.40 (1.03--1.90)     35.7         0.161               0.671                        0.995   0.979
  Only studies with high quality, matching, HWE, and genotyping examination done bindly or quality control                                                                                                                         
  Yes                                                                                                                                  1.84 (1.22--2.77)     0.0          0.020               0.164                        0.994   0.955
  M1 Null/T1 Present/P1 Val ^1^ vs. *M1* Present/*T1* Present/*P1* IIe/IIe                                                                                                                                                         
  Overall                                                                                                                              1.54 (1.08--2.18)     81.1         0.080               0.441                        0.995   0.971
  PB                                                                                                                                   1.94 (1.08--3.48)     90.7         0.054               0.194                        0.998   0.993
  ≥ 200                                                                                                                                1.49 (1.02--2.19)     84.2         0.135               0.514                        0.997   0.988
  \> 10                                                                                                                                1.72 (1.01--2.93)     89.3         0.093               0.307                        0.998   0.993
  Non-matching                                                                                                                         2.50 (1.29--4.84)     81.0         0.015               0.065                        0.998   0.990
  Yes (HWE)                                                                                                                            1.78 (1.06--3.01)     89.0         0.071               0.262                        0.998   0.992
  M1 Present/T1 Null/P1 Val ^1^ vs. *M1* Present/*T1* Present/*P1* IIe/IIe                                                                                                                                                         
  Non-matching                                                                                                                         1.57 (1.04--2.37)     0.0          0.100               0.414                        0.997   0.987
  All two high-risk genotype *vs*. *M1* Present/*T1* Present/*P1* IIe/IIe                                                                                                                                                          
  Overall                                                                                                                              1.41 (1.08--1.83)     77.7         0.113               0.679                        0.989   0.935
  Caucasian                                                                                                                            2.07 (1.06--4.04)     78.4         0.055               0.173                        0.99    0.995
  PB                                                                                                                                   1.71 (1.06--2.75)     89.1         0.072               0.294                        0.997   0.989
  ≥ 200                                                                                                                                1.34 (1.02--1.76)     79.6         0.214               0.791                        0.994   0.978
  \< 200                                                                                                                               2.27 (1.16--4.45)     17.0         0.032               0.114                        0.998   0.993
  \> 10                                                                                                                                1.45 (1.01--2.09)     85.5         0.155               0.572                        0.997   0.988
  Non-matching                                                                                                                         2.00 (1.18--3.38)     83.1         0.028               0.141                        0.997   0.986
  Yes (HWE)                                                                                                                            1.61 (1.03--2.50)     87.0         0.095               0.376                        0.997   0.989
  M1 Null/T1 Null/P1 Val ^1^ vs. *M1* Present/*T1* Present/*P1* IIe/IIe                                                                                                                                                            
  Overall                                                                                                                              1.79 (1.19--2.67)     72.1         0.025               0.193                        0.994   0.957
  Caucasian                                                                                                                            2.64 (1.23--5.66)     61.4         0.021               0.073                        0.998   0.994
  Indian                                                                                                                               3.10 (1.77--5.42)     46.1         \<0.001             0.005                        0.994   0.930
  NPB                                                                                                                                  1.83 (1.30--2.58)     0.0          0.008               0.128                        0.986   0.815
  Healthy women                                                                                                                        2.30 (1.62--3.26)     42.0         \<0.001             0.008                        0.957   0.260
  ≥ 200                                                                                                                                1.60 (1.06--2.41)     72.5         0.084               0.379                        0.997   0.985
  \< 200                                                                                                                               4.37 (1.75--10.92)    0.0          0.003               0.011                        0.998   0.993
  \> 10                                                                                                                                1.72 (1.00--2.94)     80.3         0.094               0.308                        0.998   0.994
  ≤10                                                                                                                                  1.79 (1.19--2.70)     26.0         0.028               0.200                        0.995   0.965
  Non-matching                                                                                                                         2.99 (1.66--5.41)     55.1         0.001               0.011                        0.996   0.963
  Yes (HWE)                                                                                                                            1.87 (1.00--3.50)     80.3         0.083               0.245                        0.998   0.995
  M1 Null/T1 Null/P1 Val ^1^ vs. (All one high-risk genotypes + All two high-risk genotype + *M1* Present/*T1* Present/*P1* IIe/IIe)                                                                                               
  Overall                                                                                                                              1.51 (1.10--2.06)     63.3         0.074               0.483                        0.992   0.951
  Caucasian                                                                                                                            1.63 (1.13--2.36)     43.3         0.052               0.330                        0.995   0.967
  Indian                                                                                                                               2.58 (1.51--4.40)     0.0          0.002               0.023                        0.995   0.956
  NPB                                                                                                                                  1.75 (1.29--2.36)     29.2         0.007               0.156                        0.973   0.610
  Healthy women                                                                                                                        1.99 (1.46--2.70)     27.3         0.001               0.035                        0.944   0.221
  ≥ 200                                                                                                                                1.37 (1.00--1.88)     63.0         0.206               0.713                        0.996   0.986
  \< 200                                                                                                                               3.14 (1.47--6.72)     0.0          0.007               0.029                        0.998   0.991
  ≤10                                                                                                                                  1.56 (1.08--2.24)     33.6         0.078               0.410                        0.995   0.975
  Non-matching                                                                                                                         2.08 (1.35--3.21)     34.7         0.006               0.070                        0.993   0.931

Val ^1^:IIe/Val + Val/Val, PB: population-based studies; HB: hospital-based studies; HWE: Hardy-Weinberg equilibrium; NPB: no population-based studies

10.1371/journal.pone.0216147.t014

###### False-positive report probability values for the previous meta-analyses on *GSTM1*, *GSTT1*, and *GSTP1* IIe105Val polymorphisms with breast cancer risk.

![](pone.0216147.t014){#pone.0216147.t014g}

  Author                                                 Gene      Model                           n    Case/Control    Variable                                                                OR (95% CI)         *I*^2^ (%)   Statistical power   Prior probability of 0.001           
  ------------------------------------------------------ --------- ------------------------------- ---- --------------- ----------------------------------------------------------------------- ------------------- ------------ ------------------- ---------------------------- ------- -------
  Xue \[[@pone.0216147.ref015]\] 2016                    *GSTM1*   null vs. present                17   5,323/7,196     Chinese                                                                 1.28 (1.09--1.51)   NA           0.222               0.970                        0.939   0.778
  Xue \[[@pone.0216147.ref015]\] 2016                    *GSTM1*   null vs. present                8    NA              HB                                                                      1.55 (1.20--2.00)   NA           0.025               0.400                        0.968   0.652
  Xue \[[@pone.0216147.ref015]\] 2016                    *GSTM1*   null vs. present                11   NA              Mainland China                                                          1.42 (1.12--1.81)   NA           0.087               0.671                        0.982   0.873
  Kuang \[[@pone.0216147.ref016]\] 2016                  *GSTP1*   Val/Val vs. IIe/IIe             15   NA              HB                                                                      1.28 (1.10--1.48)   NA           0.192               0.984                        0.818   0.466
  Kuang \[[@pone.0216147.ref016]\] 2016                  *GSTP1*   Val/Val + IIe/Val vs. IIe/IIe   15   NA              HB                                                                      1.10 (1.02--1.18)   NA           0.992               1.000                        0.887   0.886
  Kuang \[[@pone.0216147.ref016]\] 2016                  *GSTP1*   Val/Val vs. IIe/IIe + IIe/Val   15   NA              HB                                                                      1.22 (1.06--1.41)   NA           0.411               0.997                        0.945   0.877
  Kuang \[[@pone.0216147.ref016]\] 2016                  *GSTP1*   Val/Val vs. IIe/IIe             12   NA              Asian                                                                   1.41 (1.06--1.88)   NA           0.136               0.663                        0.993   0.967
  Kuang \[[@pone.0216147.ref016]\] 2016                  *GSTP1*   IIe/Val vs. IIe/IIe             12   NA              Asian                                                                   1.08 (1.00--1.16)   NA           0.998               1.000                        0.972   0.972
  Kuang \[[@pone.0216147.ref016]\] 2016                  *GSTP1*   Val/Val + IIe/Val vs. IIe/IIe   12   NA              Asian                                                                   1.11 (1.04--1.19)   NA           0.986               1.000                        0.769   0.767
  Song \[[@pone.0216147.ref017]\] 2016                   *GSTM1*   null vs. present                7    NA              Asian                                                                   1.17 (1.04--1.32)   41.4         0.660               1.000                        0.942   0.915
  Song \[[@pone.0216147.ref017]\] 2016                   *GSTT1*   null vs. present                6    NA              Asian                                                                   1.19 (1.01--1.41)   43.3         0.555               1.000                        0.880   0.803
  Song \[[@pone.0216147.ref017]\] 2016                   *GSTP1*   Val/Val vs. IIe/IIe + IIe/Val   6    NA              Caucasian                                                               1.16 (1.01--1.34)   25.4         0.677               1.000                        0.985   0.978
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTT1*   null vs. present                9    2,770/3,775     East Asian                                                              1.20 (1.00--1.45)   62           0.500               0.990                        0.992   0.983
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTT1*   null vs. present                5    531/611         Premenopausal                                                           1.45 (1.10--1.93)   0            0.097               0.592                        0.991   0.948
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTT1*   null vs. present                15   2,580/2,587     HB                                                                      1.30 (1.07--1.59)   53           0.218               0.918                        0.980   0.921
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTM1*   null vs. present                27   7,409/9,301     Asian                                                                   1.18 (1.04--1.33)   65           0.608               1.000                        0.917   0.870
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTM1*   null vs. present                13   4,699/5,881     East Asian                                                              1.14 (1.01--1.27)   41           0.824               1.000                        0.955   0.946
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTM1*   null vs. present                7    1,459/1,689     Premenopausal                                                           1.51 (1.23--1.86)   40           0.015               0.475                        0.874   0.183
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTM1*   null vs. present                17   3,856/3,719     HB                                                                      1.32 (1.11--1.56)   64           0.132               0.933                        0.895   0.546
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTP1*   Val/Val vs. IIe/IIe + IIe/Val   20   8,557/9,544     Asian                                                                   1.23 (1.07--1.41)   70           0.362               0.998                        0.891   0.748
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTP1*   Val/Val vs. IIe/IIe + IIe/Val   7    6,108/6,514     East Asian                                                              1.15 (1.03--1.28)   35           0.782               1.000                        0.931   0.913
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTP1*   Val/Val vs. IIe/IIe + IIe/Val   12   2,884/2,591     HB                                                                      1.38 (1.03--1.84)   78           0.170               0.715                        0.994   0.975
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTP1*   Val/Val vs. IIe/IIe + IIe/Val   8    5,673/6,953     PB                                                                      1.10 (1.02--1.19)   0            0.985               1.000                        0.947   0.946
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTP1*   Val vs. IIe                     15   15,754/17,036   Asian                                                                   1.30 (1.12--1.51)   82           0.147               0.969                        0.801   0.380
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTP1*   Val vs. IIe                     5    11,738/12,156   East Asian                                                              1.14 (1.04--1.26)   42           0.842               1.000                        0.924   0.911
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTP1*   Val vs. IIe                     5    2,440/2,858     South Asian                                                             1.44 (1.00--2.07)   87           0.162               0.587                        0.997   0.988
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTP1*   Val vs. IIe                     8    4,750/4,008     HB                                                                      1.58 (1.14--2.19)   88           0.049               0.378                        0.992   0.941
  Tang \[[@pone.0216147.ref018]\] 2015                   *GSTP1*   Val vs. IIe                     7    11,004/13,028   PB                                                                      1.11 (1.04--1.19)   0            0.986               1.000                        0.769   0.767
  Xiao \[[@pone.0216147.ref019]\] 2015                   *GSTT1*   null vs. present                13   3,387/5,085     Chinese                                                                 1.31 (1.02--1.67)   NA           0.239               0.863                        0.992   0.971
  Xiao \[[@pone.0216147.ref019]\] 2015                   *GSTT1*   null vs. present                5    NA              HB                                                                      1.90 (1.44--2.49)   NA           \<0.001             0.043                        0.883   0.070
  Xiao \[[@pone.0216147.ref019]\] 2015                   *GSTT1*   null vs. present                3    NA              Northern Chinese                                                        2.67 (1.81--3.94)   NA           \<0.001             0.002                        0.964   0.291
  Wan \[[@pone.0216147.ref020]\] 2014                    *GSTM1*   null vs. present                15   5,176/5,890     Chinese                                                                 1.34 (1.12--1.60)   77           0.111               0.894                        0.916   0.576
  Wan \[[@pone.0216147.ref020]\] 2014                    *GSTM1*   null vs. present                12   NA              Southern Chinese                                                        1.14 (1.01--1.28)   39           0.807               1.000                        0.971   0.964
  Wan \[[@pone.0216147.ref020]\] 2014                    *GSTM1*   null vs. present                3    NA              Northern Chinese                                                        2.65 (2.04--3.34)   39           0.001               0.001                        0.999   0.999
  Wan \[[@pone.0216147.ref020]\] 2014                    *GSTM1*   null vs. present                11   NA              HB                                                                      1.34 (1.12--1.60)   50           0.113               0.892                        0.921   0.596
  Liu \[[@pone.0216147.ref021]\] 2013                    *GSTP1*   Val vs. IIe                     9    NA              Asian                                                                   1.10 (1.04--1.17)   NA           0.997               1.000                        0.712   0.711
  Liu \[[@pone.0216147.ref021]\] 2013                    *GSTP1*   Val/Val vs. IIe/IIe + IIe/Val   9    NA              Asian                                                                   1.36 (1.14--1.62)   NA           0.080               0.864                        0.876   0.398
  Liu \[[@pone.0216147.ref021]\] 2013                    *GSTP1*   Val/Val vs. IIe/IIe + IIe/Val   8    NA              Asian                                                                   1.28 (1.02--1.62)   NA           0.296               0.907                        0.993   0.978
  Liu \[[@pone.0216147.ref021]\] 2013                    *GSTP1*   Val vs. IIe                     13   NA              HB                                                                      1.11 (1.05--1.19)   NA           0.986               1.000                        0.769   0.767
  Liu \[[@pone.0216147.ref021]\] 2013                    *GSTP1*   Val/Val vs. IIe/IIe + IIe/Val   13   NA              HB                                                                      1.32 (1.12--1.55)   NA           0.122               0.941                        0.852   0.428
  Chen \[[@pone.0216147.ref022]\] 2011                   *GSTT1*   null vs. present                48   17,254/21,163   Overall                                                                 1.14 (1.05--1.23)   NA           0.907               1.000                        0.444   0.420
  Chen \[[@pone.0216147.ref022]\] 2011                   *GSTT1*   null vs. present                32   NA              Caucasian                                                               1.19 (1.08--1.31)   NA           0.568               1.000                        0.405   0.279
  Chen \[[@pone.0216147.ref022]\] 2011                   *GSTT1*   null vs. present                19   NA              HB                                                                      1.18 (1.06--1.32)   NA           0.616               1.000                        0.861   0.792
  Chen \[[@pone.0216147.ref022]\] 2011                   *GSTT1*   null vs. present                27   NA              PB                                                                      1.12 (1.01--1.24)   NA           0.908               1.000                        0.970   0.967
  Economopoulos and Lu \[[@pone.0216147.ref023]\] 2010   *GSTP1*   Val/Val vs. IIe/IIe + IIe/Val   NA   NA              Asian                                                                   1.36 (1.13--1.63)   NA           0.088               0.856                        0.909   0.505
  Economopoulos and Lu \[[@pone.0216147.ref023]\] 2010   *GSTP1*   Val/Val vs. IIe/IIe             NA   NA              HB                                                                      1.32 (1.07--1.63)   NA           0.188               0.883                        0.981   0.918
  Economopoulos and Lu \[[@pone.0216147.ref023]\] 2010   *GSTP1*   Val/Val vs. IIe/IIe + IIe/Val   NA   NA              HB                                                                      1.24 (1.01--1.51)   NA           0.372               0.971                        0.989   0.971
  Economopoulos and Lu \[[@pone.0216147.ref023]\] 2010   *GSTP1*   Val/Val + IIe/Val vs. IIe/IIe   NA   NA              HB                                                                      1.14 (1.01--1.27)   NA           0.824               1.000                        0.955   0.946
  Lu \[[@pone.0216147.ref024]\] 2011                     *GSTP1*   Val/Val vs. IIe/IIe             8    NA              Asian                                                                   1.27 (1.02--1.83)   NA           0.380               0.814                        0.998   0.996
  Lu \[[@pone.0216147.ref024]\] 2011                     *GSTP1*   Val/Val vs. IIe/IIe + IIe/Val   8    NA              Asian                                                                   1.42 (1.20--1.69)   NA           0.029               0.731                        0.730   0.097
  Lu \[[@pone.0216147.ref024]\] 2011                     *GSTP1*   Val/Val vs. IIe/IIe             13   NA              HB                                                                      1.38 (1.16--1.63)   NA           0.050               0.837                        0.750   0.152
  Lu \[[@pone.0216147.ref024]\] 2011                     *GSTP1*   Val/Val vs. IIe/IIe + IIe/Val   13   NA              HB                                                                      1.31 (1.12--1.55)   NA           0.153               0.943                        0.915   0.637
  Lu \[[@pone.0216147.ref024]\] 2011                     *GSTP1*   Val/Val + IIe/Val vs. IIe/IIe   13   NA              HB                                                                      1.10 (1.02--1.19)   NA           0.985               1.000                        0.947   0.946
  Qiu \[[@pone.0216147.ref025]\] 2010                    *GSTM1*   null vs. present                59   20,993/25,288   Overall                                                                 1.10 (1.04--1.16)   NA           0.999               1.000                        0.303   0.303
  Qiu \[[@pone.0216147.ref025]\] 2010                    *GSTM1*   null vs. present                32   NA              Caucasian                                                               1.05 (1.00--1.10)   NA           1.000               1.000                        0.975   0.975
  Qiu \[[@pone.0216147.ref025]\] 2010                    *GSTM1*   null vs. present                15   NA              Asian                                                                   1.21 (1.08--1.35)   NA           0.441               1.000                        0.593   0.391
  Qiu \[[@pone.0216147.ref025]\] 2010                    *GSTM1*   null vs. present                27   NA              PB                                                                      1.11 (1.03--1.20)   NA           0.975               1.000                        0.899   0.897
  Qiu \[[@pone.0216147.ref025]\] 2010                    *GSTM1*   null vs. present                17   NA              Postmenopausal                                                          1.15 (1.04--1.28)   NA           0.782               1.000                        0.931   0.913
  Sergentanis \[[@pone.0216147.ref026]\] 2010            *GSTT1*   null vs. present                41   16,589/19,995   Overall                                                                 1.11 (1.04--1.20)   NA           0.975               1.000                        0.654   0.639
  Sergentanis \[[@pone.0216147.ref026]\] 2010            *GSTT1*   null vs. present                33   14,139/16,465   Non-Chinese                                                             1.13 (1.04--1.22)   29.5         0.938               1.000                        0.654   0.639
  Sergentanis \[[@pone.0216147.ref026]\] 2010            *GSTP1*   Val/Val vs. IIe/IIe             5    4,256/5,173     Chinese                                                                 1.30 (1.02--1.65)   NA           0.255               0.880                        0.992   0.972
  Sergentanis \[[@pone.0216147.ref026]\] 2010            *GSTP1*   Val/Val vs. IIe/IIe + IIe/Val   5    4,256/5,173     Chinese                                                                 1.27 (1.01--1.61)   NA           0.320               0.915                        0.993   0.981
  Sull \[[@pone.0216147.ref027]\] 2004                   *GSTM1*   null vs. present                10   2,005/2,282     Postmenopausal                                                          1.19 (1.05--1.34)   NA           0.555               1.000                        0.880   0.803
  Sull \[[@pone.0216147.ref027]\] 2004                   *GSTM1*   null vs. present                15   2,682/2,813     *GSTM1* deficiency (%) [^1^](#t014fn001){ref-type="table-fn"} \< 50.4   1.20 (1.08--1.34)   NA           0.500               1.000                        0.706   0.546
  Egan \[[@pone.0216147.ref029]\] 2004                   *GSTM1*   null vs. present                11   2,521/2,963     Postmenopausal                                                          1.14 (1.02--1.27)   NA           0.824               1.000                        0.955   0.946
  Egan \[[@pone.0216147.ref029]\] 2004                   *GSTT1*   null vs. present                15   4,873/5,245     All women                                                               1.11 (1.01--1.22)   NA           0.947               1.000                        0.970   0.968

^1^ Median value was used to dichotomize the characteristics; PB: population-based studies; HB: hospital-based studies; NA: not available

Discussion {#sec019}
==========

A meta-analysis involving 101 publications was done to evaluate the relationship between individual and combined effects of *GSTM1*, *GSTT1*, and *GSTP1* polymorphisms on BC risk. We also used FPRP test and Venice criteria to re-analyze the previously published systematic meta-analyses. As far as we know, this is the first meta-analysis to investigate whether there was an increased BC risk for the combined effects of *GSTM1* present/null, *GSTT1* present/null, and *GSTP1* IIe105Val polymorphisms.

Among these genes, both *GSTM1* and *GSTT1* genes show deletion polymorphisms (null genotype), which cause the absence of expression and enzyme activity loss. *GSTP1* IIe105Val polymorphism also decreases enzymatic activity. Given the involvement of *GSTs* in deactivating and detoxifying carcinogens, deletions in *GSTM1* and *GSTT1* and IIe105Val polymorphism in *GSTP1* resulting in no enzyme activity may compromise an individual's ability to deactivate carcinogens, thus increasing risk of cancer. The exact mechanism involved are still mysterious, these combined effects might be due to the involvement of *GSTM1*, *GSTT1*, and *GSTP1* in metabolism. Moreover, each gene expresses an increased risk genotype (*GSTM1* null, *GSTT1* null and *GSTP1* Val/Val), which may be involved in breast cancer susceptibility when more than one are expressed in each individual. Overall, statistically significant increased BC risk was found in any individual and combined effects of the *GSTM1*, *GSTT1* and *GSTP1* polymorphisms. In addition, significant association was also observed in some subgroups for these genes on BC risk. However, when we restrained only high-quality studies, HWE, matching, and genotyping examination performed blindly or with quality control, significantly increased BC risk was found in the overall analysis for *GSTM1* null genotype, all populations, Caucasians, and postmenopausal women for the combined effects of *GSTM1* and *GSTT1* polymorphisms, and overall analysis for the combined effects of *GSTM1*, *GSTT1*, and *GSTP1* IIe105Val polymorphisms. This was an attempt to avoid random errors and confounding bias that sometimes distorted the results of molecular epidemiological studies \[[@pone.0216147.ref045]--[@pone.0216147.ref047]\]. Furthermore, the current meta-analysis were analyzed by applying several subgroups and different genetic models at the expense of multiple comparisons, under these circumstances, the pooled *P*-value must be adjusted \[[@pone.0216147.ref048]\]. With regard to the Venice criteria, statistical power and *I*^2^ were important indicator by Ioannidis et al. \[[@pone.0216147.ref049]\]. Hence, we used FPRP test and Venice criteria to assess positive results. Finally, we identified "less-credible positive results" for the current and previous meta-analyses when we evaluated the credibility of significant associations in the current and previous meta-analyses. Heterogeneity was also observed in the current meta-analysis. The results of meta-regression analysis suggested that source of controls, type of controls and quality score of articles were source of heterogeneity between the combined effects of *GSTM1* and *GSTT1* polymorphisms and BC risk. For the combined effects of *GSTM1* and *GSTP1* IIe105Val polymorphisms, matching was source of heterogeneity in this meta-analysis. Therefore, we should perform subgroup analyses to reduce heterogeneity, because HB, patients, low quality studies and no-matching studies were important confounding bias. In addition, random error and bias were common in the studies with small sample sizes, and the results were unreliable, especially in molecular epidemiological studies \[[@pone.0216147.ref048]\]. Furthermore, small sample studies were easier to accept if there was a positive report as they tend to yield false-positive results because they may be not rigorous and are often of low-quality. [S8](#pone.0216147.s020){ref-type="supplementary-material"}--[S19](#pone.0216147.s031){ref-type="supplementary-material"} Figs indicates that the asymmetry of the funnel plot was caused by a study with low-quality small samples.

A total of fourteen previous meta-analyses \[[@pone.0216147.ref019]--[@pone.0216147.ref032]\] between 2004 and 2016 have been published to analyze the individual *GSTM1* present/null, *GSTT1* present/null, and/or *GSTP1* IIe105Val polymorphisms on breast cancer (BC) risk. [Table 14](#pone.0216147.t014){ref-type="table"} lists the statistically significant association, *I*^2^ value, statistical power and FPRP value for the previous meta-analyses. Xue et al. \[[@pone.0216147.ref019]\] performed an association of 17 studies involving 5,323 cases and 7,196 controls in Chinese population, and suggested that the *GSTM1* null genotype contributed to an increased CRC risk in Chinese population. Kuang et al. \[[@pone.0216147.ref020]\] examined 36 studies including 20,615 cases and 20,481 controls to show that the *GSTP1* IIe105Val polymorphism was associated with an increased BC risk in Asians. The examination of 17 studies of *GSTM1* (including 4,046 cases and 5,344 controls), 14 studies of *GSTT1* (including 2,788 cases and 3,686 controls), and 10 studies of *GSTP1* (including 3,233 cases and 3,246 controls) by Song et al. \[[@pone.0216147.ref021]\] indicated that the *GSTM1* and *GSTT1* null genotypes were associated with an increased BC risk in Asians and the *GSTP1* IIe105Val polymorphism was associated with an increased BC risk in Caucasians. The examination of 27 studies of *GSTM1*, 23 studies of *GSTT1*, and 20 studies of *GSTP1* by Tang et al. \[[@pone.0216147.ref022]\] indicated that the *GSTM1* and *GSTP1* polymorphisms were associated with an increased BC risk in Asian population, especially in East Asian, while the *GSTT1* polymorphism may be not associated with BC risk. Xiao et al. \[[@pone.0216147.ref023]\] conducted an association of 13 studies involving 3,387 cases and 5,085 controls in Chinese population, and suggested that the *GSTT1* null genotype contributed to an increased BC risk in Chinese population. Wan et al. \[[@pone.0216147.ref024]\] identified 15 studies of 5,176 cases and 5,890 controls in Chinese population, and demonstrated that the *GSTM1* null genotype was associated with an increased BC risk in the Chinese population. Liu et al. \[[@pone.0216147.ref025]\] conducted an association of 35 investigations including 18,665 BC cases and 21,682 controls, and demonstrated that *GSTP1* IIe105Val polymorphism was associated with increased BC risk in Asians. Chen et al. \[[@pone.0216147.ref026]\] selected 48 studies involving 17,254 cases and 21,163 controls to suggest that the *GSTT1* null genotype may contribute to an increased BC risk in Asians and Caucasians. Economopoulos and Sergentanis \[[@pone.0216147.ref027]\] assessed the meta-analysis of Lu et al. \[[@pone.0216147.ref028]\], the results indicated that the *GSTP1* IIe105Val polymorphism was associated with an increased BC risk in Asians. Lu et al. \[[@pone.0216147.ref028]\] evaluated the association of the *GSTP1* IIe105Val polymorphism with BC risk in all races in 30 published studies (including 15,901 cases and 18,757 controls) indicated that the *GSTM1* null genotype may be associated with an increased risk of BC in Asians. Qiu et al. \[[@pone.0216147.ref029]\] identified 59 studies of 20,993 cases and 25,288 controls in all populations, and demonstrated that the *GSTM1* null genotype was associated with an increased BC risk in Caucasians and postmenopausal women. The examination of 41 studies of *GSTT1* (16,589 cases and 19,995 controls) and 30 studies of *GSTP1* (16,908 cases and 20,016 controls) by Sergentanis and Economopoulos \[[@pone.0216147.ref030]\] indicated that the *GSTT1* null genotype and *GSTP1* IIe105Val polymorphisms seemed to be associated with an increased BC risk in a race-specific manner. The finding on *GSTP1* IIe105Val polymorphisms was further investigated because of the small number of Chinese studies. Sull et al. \[[@pone.0216147.ref031]\] examined 30 studies (including 5,904 cases and 6,459 controls) to assess the *GSTM1* null genotype association with BC risk they found that the *GSTM1* null genotype was associated with an increased BC risk in postmenopausal women. The examination of 19 studies of *GSTM1* (5,950 BC cases and 6,601 controls), 15 studies of *GSTT1* (4,873 BC cases and 5,245 controls), and 10 studies of *GSTP1* (2,136 BC cases and 2,282 controls) by Egan et al. \[[@pone.0216147.ref032]\] suggested that the *GSTM1* and *GSTT1* null genotypes were associated with an increased BC risk in postmenopausal and all women, respectively. However, quality assessment of the eligible studies was not assessed in 12 previous meta-analyses \[[@pone.0216147.ref019]--[@pone.0216147.ref021], [@pone.0216147.ref023], [@pone.0216147.ref025]--[@pone.0216147.ref032]\], source of heterogeneity was not explored in 13 previous meta-analyses \[[@pone.0216147.ref019]--[@pone.0216147.ref032]\] on the basis of meta-regression analysis, the false-positive report probabilities of statistically significant association and statistical power was not evaluated in all previous meta-analyses \[[@pone.0216147.ref019]--[@pone.0216147.ref032]\], and *I*^2^ value was not showed in 11 previous meta-analyses \[[@pone.0216147.ref019], [@pone.0216147.ref020], [@pone.0216147.ref023], [@pone.0216147.ref025]--[@pone.0216147.ref032]\]. Therefore, results of their meta-analyses may be not credible.

This meta-analysis has several advantages over previous meta-analyses \[[@pone.0216147.ref019]--[@pone.0216147.ref032]\]. First, the sample size was much larger, with 88 studies involving 28,676 BC cases and 32,539 controls assessed for the *GSTM1* null genotype, 67 studies involving 23,092 BC cases and 26,381 controls for the *GSTT1* null genotype, and 56 studies involving 25,331 BC cases and 27,424 controls in all populations. Second, this is the first meta-analysis to investigate the combined effects of these genes in overall population. Third, we evaluated quality assessment of the eligible studies. Forth, we used meta-regression analysis method to explore the source of heterogeneity. Fifth, we collected more detailed data. Sixth, an important sensitivity analysis was conducted on studies that were high-quality, matching, HWE, and or in which genotyping was performed blindly or with quality control. Seventh, we applied FPRP and Venice criteria to investigate the significant association with BC risk. The current meta-analysis also has several limitations. First, only published articles were included in the current meta-analysis, therefore, publication bias may be exist as shown in [S8](#pone.0216147.s020){ref-type="supplementary-material"}--[S19](#pone.0216147.s031){ref-type="supplementary-material"} Figs. Positive results are known to be published more readily than negative ones. If negative results were included, an underestimation of the *GSTM1* null effect may be observed. Second, we did not consider whether the genotype distribution in the controls was in HWE for *GSTM1* and *GSTT1* polymorphism because we cannot calculate the HWE on the both genes. Third, no data were extracted on other risk factors, such as hormonal readiness, obesity, smoking, and so on.

Conclusions {#sec020}
===========

In summary, this meta-analysis indicates that individual and combined effects of *GSTM1*, *GSTT1* and *GSTP1* polymorphisms may be not associated with increased BC risk.
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(PDF)

###### 

Click here for additional data file.

###### Genotype frequencies of the *GSTM1*, *GSTT1*, and *GSTP1* IIe105Val polymorphisms between postmenopausal and premenopausal breast cancer and control groups.

(PDF)

###### 

Click here for additional data file.

###### Genotype frequencies of the *GSTM1*, *GSTT1*, and *GSTP1* IIe105Val polymorphisms between and breast cancer and control groups by smoking status.

(PDF)

###### 

Click here for additional data file.

###### Genotype frequencies of the combined effects of *GSTM1* present/null and *GSTT1* present/null between breast cancer and control groups.

(PDF)

###### 

Click here for additional data file.

###### Genotype frequencies of the combined effects of GSTM1 and GSTT1 between postmenopausal and premenopausal breast cancer and control groups.

(PDF)

###### 

Click here for additional data file.

###### Genotype frequencies of the combined effects of *GSTM1* present/null and *GSTP1* IIe105Val between breast cancer and control groups.

(PDF)

###### 

Click here for additional data file.

###### Genotype frequencies of the combined effects of *GSTT1* present/null and *GSTP1* IIe105Val between breast cancer and control groups.

(PDF)

###### 

Click here for additional data file.

###### Genotype frequencies of the combined effects of *GSTM1* present/null, *GSTT1* present/null, and *GSTP1* IIe105Val between breast cancer and control groups.

(PDF)

###### 

Click here for additional data file.

###### Begg's funnel plot to assess publication bias on *GSTM1* polymorphism in overall population.

(PDF)

###### 

Click here for additional data file.

###### Begg's funnel plot to assess publication bias on *GSTT1* polymorphism in overall population.

(PDF)

###### 

Click here for additional data file.

###### Begg's funnel plot to assess publication bias on *GSTP1* polymorphism in overall population (Val/Val vs. IIe/IIe).

(PDF)

###### 

Click here for additional data file.

###### Begg's funnel plot to assess publication bias on *GSTP1* polymorphism in overall population (IIe/Val vs. IIe/IIe).

(PDF)

###### 

Click here for additional data file.

###### Begg's funnel plot to assess publication bias on *GSTP1* polymorphism in overall population (Val/Val vs. IIe/IIe +IIe/Val).

(PDF)

###### 

Click here for additional data file.

###### Begg's funnel plot to assess publication bias on *GSTP1* polymorphism in overall population (Val vs. IIe).

(PDF)

###### 

Click here for additional data file.

###### Begg's funnel plot to assess publication bias on GSTP1 polymorphism in overall population (Val/Val + IIe/Val vs. IIe/IIe).

(PDF)

###### 

Click here for additional data file.

###### "trim and fill" plots for the publication bias evaluation between the combined effects of *GSTM1* and *GSTT1* polymorphisms and breast cancer risk (*− − vs*. (*+ +*)).

(PDF)

###### 

Click here for additional data file.

###### "trim and fill" plots for the publication bias evaluation between the combined effects of *GSTM1* and *GSTT1* polymorphisms and breast cancer risk ((+ *−*) + (*−* +) vs. (+ +)).

(PDF)

###### 

Click here for additional data file.

###### "trim and fill" plots for the publication bias evaluation between the combined effects of *GSTM1* and *GSTT1* polymorphisms and breast cancer risk ((*−* +) + (+ *−*) + (*− −*) vs. + +).

(PDF)

###### 

Click here for additional data file.

###### "trim and fill" plots for the publication bias evaluation between the combined effects of *GSTM1* and *GSTT1* polymorphisms and breast cancer risk (*− −* vs. (*−* +) + (+ *−*) + (+ +)).

(PDF)

###### 

Click here for additional data file.

###### "trim and fill" plots for the publication bias evaluation between the combined effects of *GSTM1* and *GSTP1* polymorphisms and breast cancer risk (*GSTM1* null/*GSTP1* Val\* vs. *GSTM1* present/GSTP1 IIe/IIe).

(PDF)

###### 

Click here for additional data file.

###### "trim and fill" plots for the publication bias evaluation between the combined effects of *GSTM1* and *GSTP1* polymorphisms and breast cancer risk (All risk genotypes vs. *GSTM1* present/*GSTP1* IIe/IIe).

(PDF)

###### 

Click here for additional data file.

###### "trim and fill" plots for the publication bias evaluation between the combined effects of *GSTT1* and *GSTP1* polymorphisms and breast cancer risk (*GSTT1* null/*GSTP1* val\* vs. *GSTT1* present/*GSTP1* IIe/IIe).

(PDF)

###### 

Click here for additional data file.

###### "trim and fill" plots for the publication bias evaluation between the combined effects of *GSTT1* and *GSTP1* polymorphisms and breast cancer risk (All risk genotypes vs. *GSTT1* present/*GSTP1* IIe/IIe).

(PDF)

###### 

Click here for additional data file.

###### "trim and fill" plots for the publication bias evaluation between the combined effects of *GSTT1* and *GSTP1* polymorphisms and breast cancer risk (*GSTT1* null/*GSTP1* Val\* vs. *GSTT1* null/*GSTP1* IIe/IIe + *GSTT1* present/*GSTP1* Val\* + *GSTT1* present/*GSTP1* IIe/IIe).

(PDF)

###### 

Click here for additional data file.

###### "trim and fill" plots for the publication bias evaluation between the combined effects of *GSTT1*, *GSTM1* and *GSTP1* polymorphisms and breast cancer risk (All two high-risk genotype vs. M1 present/T1 present/P1 IIe/IIe).

(PDF)

###### 

Click here for additional data file.

###### "trim and fill" plots for the publication bias evaluation between the combined effects of GSTT1, GSTM1 and GSTP1 polymorphisms and breast cancer risk (M1 null/T1 null/P1 Val \* vs.M1 present/T1 present/P1 IIe/IIe).

(PDF)

###### 

Click here for additional data file.

###### "trim and fill" plots for the publication bias evaluation between the combined effects of *GSTT1*, *GSTM1* and *GSTP1* polymorphisms and breast cancer risk (M1 null/T1 null/P1 Val\* vs. M1 present/T1 present/P1 IIe/IIe + all one high risk + all two high risk).

(PDF)

###### 

Click here for additional data file.

###### References.

(PDF)

###### 

Click here for additional data file.

###### Prototype Excel spreadsheet showing input and output for false positive report probability (FPRP) calculations.

(XLS)

###### 

Click here for additional data file.

###### Prisma checklist.

(DOC)

###### 

Click here for additional data file.

###### Meta analysis on genetic association studies form.

(DOCX)

###### 

Click here for additional data file.
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